Restless leg syndrome

G6_RLS

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Primary healthcare outpatient: ICD-10 — G25.8 Hospital discharge: ICD-10 — G25.8 Cause of death: ICD-10 — G25.8 3 out of 7 registries used, show all original rules.	6998
4. Check minimum number of events None	6998
5. Include endpoints None	6998
6. Filter based on genotype QC (FinnGen only)	6380

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF10

NAME	G6_RLS
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD	G258
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	G258
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	G258
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Restless leg syndrome based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	22541	14134	8331
Only index persons	21977	13876	8101
Unadjusted period prevalence (%)
Whole population	0.34	0.40	0.23
Only index persons	0.44	0.51	0.31
Median age at first event (years)
Whole population	64.52	65.47	63.04
Only index persons	64.47	65.40	62.88

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	6380	4349	2031
Unadjusted period prevalence (%)	1.35	1.54	0.93
Median age at first event (years)	62.92	61.95	65.00

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
6596: Matched controls
65960

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

N03AX12

ATC

[U] gabapentin; oral

3.5

307.7

1900

6877

N04BC04

ATC

ropinirole; oral

15.5

307.7

348

236

N03AX16

ATC

[U] pregabalin

3.0

307.7

2365

10326

IAB13

NOMESCO Finland

Psychiatric sleep disorder consultation

76.2

307.7

178

N02BF02

ATC

pregabalin; oral

4.2

307.7

959

2545

F51.0

ICD-10 Finland

Nonorganic insomnia

3.4

307.7

2009

7449

N04

ICPC

Restless legs

71.7

307.7

479

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

+∞

307.7

6596

N04BC05

ATC

pramipexole; oral

59.0

307.7

4464

2259

N02BF01

ATC

gabapentin; oral

5.1

307.7

1719

4247

N04BA02

ATC

levodopa and decarboxylase inhibitor; oral

7.3

307.7

668

1002

N06AX11

ATC

mirtazapine; oral

3.0

307.7

3368

16823

N05AH04

ATC

quetiapine; oral

3.1

307.7

1825

7276

G47.3

ICD-10 Finland

Sleep apnoea

2.9

307.7

2243

9822

N03AE01

ATC

clonazepam; systemic

4.4

277.7

770

1938

N06AX21

ATC

duloxetine; oral

3.1

255.5

1326

5024

M79.6

ICD-10 Finland

Pain in limb

2.3

230.3

3676

23386

N05CF01

ATC

zopiclone; oral

2.3

230.1

2699

15097

P06

ICPC

Sleep disturbance

2.8

210.9

1306

5397

N06AX16

ATC

venlafaxine; oral

2.7

208.9

1388

5943

N05BA04

ATC

oxazepam; oral

2.3

206.9

2276

12268

R53

ICD-10 Finland

Malaise and fatigue

2.3

197.2

2214

11989

N05CF02

ATC

zolpidem; oral

2.5

194.7

1589

7482

M54.5

ICD-10 Finland

Low back pain

2.1

178.7

2980

18664

N02AX02

ATC

tramadol; systemic, rectal

2.1

177.6

3284

21348

G25.9

ICD-10 Finland

Extrapyramidal and movement disorder, unspecified

9.0

169.1

210

239

N04BC09

ATC

rotigotine; transdermal

15.6

166.9

145

N02AJ06

ATC

codeine and paracetamol; systemic

2.0

166.2

3327

22075

IEY18

NOMESCO Finland

Psychiatric sleep coaching, individual

53.0

164.6

N06AX12

ATC

bupropion; oral

3.2

162.8

723

2466

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.5

160.4

1160

5117

N06AB10

ATC

escitalopram; oral

2.2

155.2

1695

8932

L17

ICPC

Foot/toe symptom/complaint

2.0

152.4

2494

15278

N06AB04

ATC

citalopram; systemic

2.2

147.8

1709

9186

L03

ICPC

Low back symptom/complaint

2.0

140.0

2377

14647

N06AX26

ATC

vortioxetine; oral

2.9

139.2

739

2778

R06.0

ICD-10 Finland

Dyspnoea

2.0

138.5

2140

12752

Z76.0

ICD-10 Finland

Issue of repeat prescription

2.0

136.7

2171

13050

A06AC01

ATC

ispaghula (psylla seeds); oral

2.0

132.1

2108

12663

M03BX02

ATC

tizanidine; oral

1.9

130.8

4420

33817

G47.9

ICD-10 Finland

Sleep disorder, unspecified

4.1

127.5

363

920

C07AA05

ATC

propranolol; systemic

2.1

124.3

1593

8822

R03AC02

ATC

salbutamol; inhalant

1.8

120.1

3921

29284

A02BC02

ATC

pantoprazole; systemic

2.0

120.0

4852

38771

M79.1

ICD-10 Finland

Myalgia

2.2

117.8

1268

6559

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.4

116.7

891

3989

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.6

116.5

769

3217

M25.5

ICD-10 Finland

Pain in joint

1.8

116.1

2548

16817

M01AH05

ATC

etoricoxib; oral

1.9

115.7

4400

34248

A02BC05

ATC

esomeprazole; systemic

1.8

114.8

2980

20673

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.2

113.6

1146

5770

M54.4

ICD-10 Finland

Lumbago with sciatica

2.0

112.4

1478

8223

G25

ICD-10 Finland

Other extrapyramidal and movement disorders

29.9

112.0

F51.9

ICD-10 Finland

Nonorganic sleep disorder, unspecified

4.4

109.1

280

655

N06AB06

ATC

sertraline; oral

2.3

109.1

951

4503

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.8

107.8

3126

22264

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.8

104.3

2688

18452

N06AA09

ATC

amitriptyline; systemic

2.4

102.1

817

3722

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.9

101.1

513

1871

R06.5

ICD-10 Finland

Mouth breathing

2.4

98.8

732

3220

R5140

NOMESCO Finland

Monitoring the use of the aid

2.3

97.7

869

4139

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.5

97.5

688

2960

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.8

97.4

2237

14778

M79.7

ICD-10 Finland

Fibromyalgia

3.3

95.5

387

1240

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

3.5

95.3

341

1010

R42

ICD-10 Finland

Dizziness and giddiness

1.8

95.1

1759

10874

R52.9

ICD-10 Finland

Pain, unspecified

2.2

94.9

879

4253

N02BE01

ATC

paracetamol; systemic, rectal

2.6

94.8

6081

54179

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

3.1

94.1

427

1462

N06AX22

ATC

agomelatine; oral

4.1

90.9

255

638

G04BD12

ATC

mirabegron; oral

2.1

90.0

983

5068

N06AB03

ATC

fluoxetine; oral

2.1

89.7

962

4924

L01

ICPC

Neck symptom/complaint

1.9

89.3

1312

7513

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.2

89.0

882

4379

G47.0

ICD-10 Finland

Disorders of initiating and maintaining sleep [insomnias]

3.8

88.6

275

740

N06AX05

ATC

trazodone; oral

3.9

88.3

270

719

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.1

87.4

975

5063

R07.4

ICD-10 Finland

Chest pain, unspecified

1.7

87.1

2033

13401

R51.80

ICD-10 Finland

Headache

1.9

86.1

1224

6924

M48.0

ICD-10 Finland

Spinal stenosis

2.1

85.5

945

4887

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.2

85.4

788

3798

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.6

85.0

543

2223

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.7

84.0

2059

13728

M09AA72

ATC

quinine, combinations with psycholeptics; systemic

3.7

83.7

273

760

M03BC01

ATC

orphenadrine (citrate); systemic

1.8

83.1

1610

10029

G20

ICD-10 Finland

Parkinson disease

3.5

83.0

297

879

N05BA01

ATC

diazepam; systemic, rectal

2.1

82.7

961

5058

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

2.2

82.0

797

3918

G44.2

ICD-10 Finland

Tension-type headache

2.0

81.4

1083

5978

P03

ICPC

Feeling depressed

2.2

81.3

781

3822

N05CD07

ATC

temazepam; oral

2.1

80.8

831

4175

R01AD09

ATC

mometasone; nasal

1.6

80.1

3135

23526

110

Kela drug reimbursment

Parkinson's disease and comparable movement disrorders

3.6

79.9

276

798

G47.2

ICD-10 Finland

Disorders of the sleep-wake schedule

13.6

79.2

Z71.8

ICD-10 Finland

Other specified counselling

1.7

78.8

2415

17021

F51

ICD-10 Finland

Nonorganic sleep disorders

2.9

78.5

395

1430

M01AE02

ATC

naproxen; oral, rectal

1.6

78.4

3784

29836

M70.6

ICD-10 Finland

Trochanteric bursitis

1.9

77.8

1104

6220

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.7

77.7

1835

12062

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.2

76.0

697

3344

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.5

75.6

516

2177

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.6

75.5

3377

26035

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.7

75.5

1974

13316

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

2.2

75.3

669

3167

A04

ICPC

Weakness/tiredness general

1.9

75.2

1204

7049

N06AX03

ATC

mianserin; oral

2.8

74.8

404

1519

E61.1

ICD-10 Finland

Iron deficiency

3.5

74.1

259

755

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.8

74.0

1354

8255

M03BC51

ATC

orphenadrine, combinations; systemic

1.7

73.9

1883

12600

R20.2

ICD-10 Finland

Paraesthesia of skin

2.3

73.4

597

2723

F41.1

ICD-10 Finland

Generalized anxiety disorder

2.6

73.3

439

1739

F32

ICD-10 Finland

Depressive episode

2.6

72.7

444

1776

P76

ICPC

Depressive disorder

2.4

72.4

544

2396

M01AB05

ATC

diclofenac; systemic, rectal

1.6

72.4

4374

36084

N03AX09

ATC

lamotrigine; oral

2.7

72.0

403

1543

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.1

71.7

732

3658

A01

ICPC

Pain general/multiple sites

2.0

71.5

819

4274

Z01.8

ICD-10 Finland

Other specified special examinations

1.7

70.6

1626

10568

J45.9

ICD-10 Finland

Asthma, unspecified

1.8

69.5

1379

8590

P01

ICPC

Feeling anxious/nervous/tense

2.0

68.9

894

4872

N05BA12

ATC

alprazolam; oral

2.1

68.3

749

3842

IDY03

NOMESCO Finland

Systematic individual therapy, cognitive-behavioural

3.0

67.8

308

1053

R02

ICPC

Shortness of breath/dyspnoea

1.9

67.7

1015

5801

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.7

66.9

372

1418

H02AB06

ATC

prednisolone; systemic

1.6

66.8

3177

24576

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.9

66.8

1032

5953

SAA01

NOMESCO Finland

Simple examination of mouth

1.6

66.5

4768

40526

Z01.2

ICD-10 Finland

Dental examination

1.6

66.3

3156

24406

F32.1

ICD-10 Finland

Moderate depressive episode

2.4

66.2

474

2041

S18

ICPC

Laceration/cut

1.6

66.1

3162

24472

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.6

65.4

3142

24317

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

2.1

64.8

720

3709

R01AD58

ATC

fluticasone, combinations; nasal

1.7

64.6

1739

11733

J45

ICD-10 Finland

Asthma

2.0

63.9

805

4334

R03DC03

ATC

montelukast; oral

1.8

63.1

1199

7352

R4110, ,

SPAT

1.8

62.7

1021

5978

L28

ICPC

Limited function/disability (L)

1.7

62.2

1351

8599

A02BC01

ATC

omeprazole; systemic

1.6

61.6

1814

12489

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.6

61.3

1675

11318

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.0

61.1

776

4187

J01AA02

ATC

doxycycline; systemic

1.7

61.0

5108

44508

AA1AD

NOMESCO Finland

CT of head and brain

1.6

61.0

1935

13559

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.9

60.8

933

5358

R35

ICD-10 Finland

Polyuria

2.3

60.8

511

2358

AA5EN

NOMESCO Finland

Brain reseptor or transprot protein distribution isotope imaging

9.1

60.7

F34.1

ICD-10 Finland

Dysthymia

2.8

60.2

309

1129

L13

ICPC

Hip symptom/complaint

1.7

59.5

1422

9271

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.5

59.5

2947

22793

R25.2

ICD-10 Finland

Cramp and spasm

3.3

58.9

228

709

N06AB05

ATC

paroxetine; oral

2.3

58.8

457

2039

A02BC03

ATC

lansoprazole; oral

1.6

58.3

1877

13171

R52.2

ICD-10 Finland

Other chronic pain

2.7

58.2

330

1270

R06AE07

ATC

cetirizine; oral

1.5

57.9

2950

22906

N87

ICPC

Parkinsonism

4.0

57.9

164

413

J02AC01

ATC

fluconazole; systemic

1.5

57.7

2708

20658

K30

ICD-10 Finland

Functional dyspepsia

1.9

57.7

857

4864

R05

ICD-10 Finland

Cough

1.6

57.2

1516

10136

F90.0

ICD-10 Finland

Disturbance of activity and attention

2.9

57.1

273

960

L08

ICPC

Shoulder symptom/complaint

1.6

57.1

1618

11001

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.3

56.9

439

1951

N06AA06

ATC

trimipramine; systemic

3.3

56.8

218

674

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.5

56.6

2726

20887

E0000UV, ,

ATC

1.5

56.0

2780

21418

M54

ICD-10 Finland

Dorsalgia

1.8

55.9

901

5244

L15

ICPC

Knee symptom/complaint

1.6

55.4

1764

12318

Z01.7

ICD-10 Finland

Laboratory examination

1.7

55.2

1188

7514

J31.0

ICD-10 Finland

Chronic rhinitis

2.0

55.2

644

3368

R06AX27

ATC

desloratadine; oral

1.6

55.1

1940

13860

SAA02

NOMESCO Finland

Basic examination of mouth

1.5

54.6

4361

36995

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.8

54.6

931

5508

WX723

NOMESCO Finland

CPAP therapy

2.5

54.6

347

1412

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

2.9

54.3

266

948

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.9

54.0

734

4043

J01DB01

ATC

cefalexin; oral

1.7

53.8

5407

48252

M01AC06

ATC

meloxicam; systemic, rectal

1.5

53.6

2380

17864

WX780

NOMESCO Finland

Remote monitoring CPAP

2.5

53.2

348

1435

R01AD12

ATC

fluticasone furoate; nasal

1.5

53.0

2079

15187

L02

ICPC

Back symptom/complaint

1.9

53.0

762

4274

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.7

52.9

298

1143

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

3.6

52.1

173

487

R00.2

ICD-10 Finland

Palpitations

2.0

52.0

608

3179

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.9

51.9

716

3962

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

3.2

51.7

207

657

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

3.5

51.3

177

511

N06BA04

ATC

methylphenidate; oral

2.9

51.2

244

856

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.8

51.0

944

5715

L12

ICPC

Hand/finger symptom/complaint

1.7

50.5

1201

7782

A02BC04

ATC

rabeprazole; oral

1.9

49.9

641

3460

WX110

NOMESCO Finland

Infiltration anesthesia

1.5

49.6

4667

40502

A98

ICPC

Health maint/preventive medicine

3.3

49.0

6454

61438

UJF32

NOMESCO Finland

Coloscopy

1.6

48.9

1697

12026

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

2.7

48.4

262

984

R01AD08

ATC

fluticasone; nasal

1.5

48.1

1868

13558

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.8

48.0

848

5057

N30.0

ICD-10 Finland

Acute cystitis

1.6

47.8

1241

8206

R12

ICD-10 Finland

Heartburn

1.9

47.8

626

3400

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.6

47.7

1288

8601

SFA20

NOMESCO Finland

Two-surface restoration

1.5

47.3

3769

31487

M01AE03

ATC

ketoprofen; systemic, rectal

1.5

47.2

2302

17494

SFA10

NOMESCO Finland

One-surface restoration

1.5

47.2

3555

29378

R03BA08

ATC

ciclesonide; inhalant

1.9

46.8

630

3451

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.6

46.8

1202

7924

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

3.4

46.5

172

520

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.8

46.4

757

4408

P29

ICPC

Psychological sympt/compl other

2.0

46.2

520

2678

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.7

45.9

965

6038

R60.0

ICD-10 Finland

Localized oedema

1.7

45.9

892

5463

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.4

45.8

3550

29423

G43.9

ICD-10 Finland

Migraine, unspecified

2.1

45.4

445

2177

K02.1

ICD-10 Finland

Caries of dentine

1.4

45.2

3755

31490

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.5

45.1

2735

21626

H04.10

ICD-10 Finland

Dry eye syndrome

1.7

44.8

857

5221

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.7

44.2

890

5498

J01CA04

ATC

amoxicillin; systemic

1.6

44.2

5284

47502

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.5

44.0

1653

11868

D01

ICPC

Abdominal pain/cramps general

1.7

44.0

864

5302

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.8

43.9

682

3908

C07AB07

ATC

bisoprolol; oral

1.4

43.9

3000

24215

R25.1

ICD-10 Finland

Tremor, unspecified

2.6

43.6

251

973

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

2.1

43.5

422

2057

N06AA12

ATC

doxepin; systemic

2.2

43.2

363

1671

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.2

43.1

403

1936

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.6

43.0

1243

8414

N05AX12

ATC

aripiprazole; systemic

2.5

42.6

276

1132

F45.8

ICD-10 Finland

Other somatoform disorders

2.0

42.5

480

2474

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.8

42.5

681

3938

C10AA07

ATC

rosuvastatin; oral

1.5

42.4

2164

16506

R05

ICPC

Cough

1.5

42.2

1665

12061

U02

ICPC

Urinary frequency/urgency

1.6

42.2

1058

6917

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.7

42.1

798

4845

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

2.0

42.0

453

2296

XKD00

NOMESCO Finland

Uroflowmetry

1.7

41.9

819

5014

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.7

41.9

942

5988

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.6

41.8

1195

8059

M01AH01

ATC

celecoxib; oral

1.6

41.8

1166

7818

H03AA01

ATC

levothyroxine sodium; systemic

1.5

41.8

1570

11254

R03BA02

ATC

budesonide; inhalant

1.6

41.8

1165

7812

SPAT1240

SPAT

Therapeutic discussion

1.8

41.8

673

3897

SPAT1249

SPAT

Treatment-related counselling outside office

1.4

41.7

2449

19167

L14

ICPC

Leg/thigh symptom/complaint

1.9

41.6

582

3225

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.8

41.6

652

3745

G47.8

ICD-10 Finland

Other sleep disorders

3.3

41.3

155

473

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

41.2

3308

27369

U07

ICPC

Urine symptom/complaint other

1.8

40.9

616

3494

N05AA02

ATC

levomepromazine; systemic

2.5

40.9

265

1088

A97

ICPC

No disease

1.6

40.8

1324

9187

SPAT1301

SPAT

No procedures

1.5

40.8

1941

14582

N03AG01

ATC

valproic acid; systemic, rectal

2.1

40.6

401

1967

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.5

40.5

1885

14097

P20

ICPC

Memory disturbance

1.7

40.4

914

5816

N17

ICPC

Vertigo/dizziness

1.7

40.1

890

5635

D11

ICPC

Diarrhoea

1.7

39.9

803

4951

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.5

39.9

1394

9823

R5110, ,

SPAT

1.8

39.9

617

3526

IBA03

NOMESCO Finland

Psychotherapy evaluation

4.6

39.6

211

R03AK07

ATC

formoterol and budesonide; inhalant

1.5

39.2

1373

9678

N05AH03

ATC

olanzapine; systemic

2.1

39.1

411

2062

N03AX11

ATC

topiramate; oral

2.8

38.8

196

710

J20

ICD-10 Finland

Acute bronchitis

1.8

38.8

699

4179

N05AN01

ATC

lithium; oral

2.9

38.7

180

623

UKC02

NOMESCO Finland

Cystoscopy

1.6

38.6

919

5919

R11

ICD-10 Finland

Nausea and vomiting

1.8

38.6

603

3456

D07AB02

ATC

hydrocortisone butyrate; topical

1.5

38.5

1871

14081

IHZ05, ,

SPAT

2.3

38.4

287

1256

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.8

38.4

666

3938

K59.09

ICD-10 Finland

Constipation, unspecified

1.9

38.1

480

2568

M01AG02

ATC

tolfenamic acid; oral, rectal

1.6

38.1

984

6466

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.8

37.8

574

3260

R51

ICD-10 Finland

Headache

2.1

37.8

398

1999

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.4

37.7

2917

23834

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

3.0

37.7

174

600

K59.0

ICD-10 Finland

Constipation

2.1

37.6

397

1996

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

1.9

37.4

481

2590

P01AB01

ATC

metronidazole; oral, rectal

1.4

37.4

2549

20374

F31.8

ICD-10 Finland

Other bipolar affective disorders

3.2

37.1

147

464

R60.9

ICD-10 Finland

Oedema, unspecified

2.0

37.0

412

2111

R07.3

ICD-10 Finland

Other chest pain

1.7

36.8

695

4206

R74

ICPC

Upper respiratory infection acute

1.4

36.7

2072

16003

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

1.9

36.6

489

2666

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

2.5

36.6

234

954

P74

ICPC

Anxiety disorder/anxiety state

2.2

36.5

322

1510

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.6

36.4

1028

6891

R21

ICPC

Throat symptom/complaint

1.5

36.3

1312

9290

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.8

36.3

546

3092

D07AC01

ATC

betamethasone; topical

1.4

36.2

2296

18096

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

2.6

36.1

208

807

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

1.7

35.9

752

4680

L16

ICPC

Ankle symptom/complaint

1.7

35.9

810

5140

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

3.2

35.8

144

459

WX290

NOMESCO Finland

Other blockage of nerve

1.4

35.7

2917

23976

F33

ICD-10 Finland

Recurrent depressive disorder

2.8

35.7

184

674

ZY010

NOMESCO Finland

Hospital outpatient

2.1

35.6

341

1653

K59.1

ICD-10 Finland

Functional diarrhoea

2.0

35.5

402

2072

A06AC51

ATC

ispaghula, combinations; oral

2.1

35.5

343

1668

ZYC01

NOMESCO Finland

Remote contact by phone

2.0

35.5

422

2213

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.5

35.3

1397

10070

SPAT1263

SPAT

Sampling

1.4

35.3

2569

20705

EB1VA, ,

NOMESCO Finland

1.5

35.2

1158

8028

A06AD11

ATC

lactulose; oral

1.6

35.1

868

5633

K21

ICD-10 Finland

Gastro-oesophageal reflux disease

1.9

35.1

430

2278

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

2.6

34.9

214

856

G04CA01

ATC

alfuzosin; oral

1.8

34.8

600

3537

N06BA07

ATC

modafinil; oral

7.4

34.7

S29

ICPC

Skin symptom/complaint other

1.5

34.6

1336

9578

A02BA02

ATC

ranitidine; systemic

1.5

34.5

1159

8068

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

1.8

34.5

574

3348

S01GX01

ATC

cromoglicic acid; ophthalmic

1.5

34.5

1288

9168

OAA65, ,

SPAT

1.5

34.4

1105

7618

R06AX22

ATC

ebastine; oral

1.5

34.3

1095

7541

G93.3

ICD-10 Finland

Postviral fatigue syndrome

6.3

34.2

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.8

34.0

569

3325

J01FA10

ATC

azithromycin; systemic

1.4

33.9

3577

30546

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.5

33.9

1407

10229

R03BA01

ATC

beclometasone; inhalant

1.6

33.8

878

5764

M54.2

ICD-10 Finland

Cervicalgia

1.8

33.7

548

3174

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.4

33.7

1865

14306

M02AA07

ATC

piroxicam; topical

1.4

33.6

2185

17235

G04CA02

ATC

tamsulosin; oral

1.5

33.4

1077

7427

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.5

33.2

1370

9941

A11

ICPC

Chest pain NOS

1.8

33.2

579

3424

M54.1

ICD-10 Finland

Radiculopathy

2.2

33.0

289

1351

SFA30

NOMESCO Finland

Three-surface restoration

1.4

33.0

2629

21430

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

2.9

33.0

154

535

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

32.9

1817

13920

R03BA05

ATC

fluticasone; inhalant

1.5

32.8

1119

7808

TAB00

NOMESCO Finland

Lumbar puncture

2.2

32.8

296

1401

G43

ICD-10 Finland

Migraine

2.0

32.8

346

1738

M54.6

ICD-10 Finland

Pain in thoracic spine

1.8

32.7

499

2835

IGY02

NOMESCO Finland

Psychiatric monitoring contact

2.5

32.7

215

889

R25.8

ICD-10 Finland

Other and unspecified abnormal involuntary movements

7.6

32.7

SAA03

NOMESCO Finland

Extended examination of mouth

1.4

32.6

2401

19312

XG466

NOMESCO Finland

Sleep oxymetry

2.5

32.6

206

836

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.5

32.4

200

802

SPAT1216

SPAT

Assessment of functional ability

1.6

32.4

943

6353

N39.3

ICD-10 Finland

Stress incontinence

1.8

32.4

533

3098

G04BD08

ATC

solifenacin; oral

1.9

32.4

434

2368

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

2.5

32.3

199

798

D82

ICPC

Teeth/gum disease

1.4

32.1

2318

18574

R13

ICD-10 Finland

Dysphagia

1.8

32.1

471

2645

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.5

31.9

1413

10383

XA800

NOMESCO Finland

Neuropsychological investigation

2.2

31.9

276

1284

L29.9

ICD-10 Finland

Pruritus, unspecified

2.4

31.8

215

900

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.5

31.8

1027

7078

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.7

31.8

707

4464

C10AA05

ATC

atorvastatin; oral

1.4

31.7

2539

20672

AA40B, ,

NOMESCO Finland

6.2

31.7

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.6

31.6

838

5522

Z2445

NOMESCO Finland

Psychologist

2.3

31.6

244

1083

SPAT1260

SPAT

Consultation of another employee

1.5

31.6

1063

7389

L29

ICPC

Musculoskeletal sympt/complt other

1.7

31.5

605

3674

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.8

31.4

461

2587

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.3

31.4

243

1080

N01

ICPC

Headache

1.6

31.3

709

4497

SDA03

NOMESCO Finland

Periodontal treatment

1.4

31.2

2551

20827

N30

ICD-10 Finland

Cystitis

1.7

30.9

575

3460

F41.09

ICD-10 Finland

UNS Panic Syndrome

2.5

30.9

203

839

J01MA02

ATC

ciprofloxacin; systemic

1.4

30.8

2313

18616

M01AX05

ATC

glucosamine; oral

1.5

30.7

1183

8455

OAB93, ,

SPAT

1.9

30.6

428

2366

IBB02

NOMESCO Finland

Psychiatric evaluation of working capacity and rehabilitation

5.1

30.5

127

F41.8

ICD-10 Finland

Other specified anxiety disorders

2.4

30.5

219

942

SPAT1153

SPAT

Removal of sutures

1.4

30.3

1893

14771

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

2.2

30.2

263

1228

D09

ICPC

Nausea

2.1

30.1

311

1550

SPAT1310

SPAT

Counselling related to known health issue

1.4

30.1

1895

14806

D19

ICPC

Teeth/gum symptom/complaint

1.4

30.1

1918

15017

R03AK08

ATC

formoterol and beclometasone; inhalant

2.0

30.0

315

1580

WZA90

NOMESCO Finland

Other medical or dental certificate

1.4

29.9

1424

10590

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.3

29.9

3077

25964

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

2.7

29.8

166

633

M02AA10

ATC

ketoprofen; topical

1.5

29.8

991

6865

R03AC03

ATC

terbutaline; inhalant

1.6

29.7

862

5795

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.4

29.7

1644

12560

A99

ICPC

Disease/condition unspecnature/site

1.6

29.6

675

4283

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.4

29.6

2463

20113

N05BE01

ATC

buspirone; oral

2.4

29.5

198

826

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

2.6

29.5

174

683

R96

ICPC

Asthma

1.6

29.5

659

4161

A28

ICPC

Limited function/disability NOS

1.5

29.4

1086

7689

Z3231

NOMESCO Finland

Registered nurse

1.4

29.3

1605

12232

R03BB04

ATC

tiotropium bromide; inhalant

1.7

29.3

575

3511

L86

ICPC

Back syndrome with radiating pain

1.8

29.2

424

2372

WZC00, ,

SPAT

1.5

29.2

945

6508

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

2.0

29.1

321

1638

M03BX01

ATC

baclofen; systemic

2.8

28.9

144

519

N06AX17

ATC

milnacipran; oral

3.6

28.8

267

Z02.7

ICD-10 Finland

Issue of medical certificate

1.8

28.8

477

2775

G47.1

ICD-10 Finland

Disorders of excessive somnolence [hypersomnias]

7.5

28.8

M01AE01

ATC

ibuprofen; systemic, rectal

1.5

28.7

5774

54087

J01EA01

ATC

trimethoprim; systemic

1.4

28.7

1629

12488

G25.0

ICD-10 Finland

Essential tremor

2.5

28.6

187

771

K08.80

ICD-10 Finland

Toothache NOS

1.7

28.6

584

3603

C09CA06

ATC

candesartan; oral

1.4

28.5

1501

11352

IGY99

NOMESCO Finland

Other psychiatric treatment contact

2.8

28.5

143

517

E66.01

ICD-10 Finland

Obesity due to excess calories

1.7

28.4

597

3710

D06

ICPC

Abdominal pain localized other

1.7

28.4

598

3719

K03.64

ICD-10 Finland

Dental calculus supragingival

1.4

28.3

2005

15935

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.3

28.3

2963

24992

N02CC05

ATC

almotriptan; oral

2.2

28.2

250

1176

H53.1

ICD-10 Finland

Subjective visual disturbances

1.8

28.1

471

2751

G23.9

ICD-10 Finland

Degenerative disease of basal ganglia, unspecified

8.8

28.0

SPAT1312

SPAT

General health counselling

1.4

27.9

1879

14805

U05

ICPC

Urination problems other

1.9

27.8

340

1798

E66.8

ICD-10 Finland

Other obesity

1.9

27.8

367

1991

D07AC13

ATC

mometasone; topical

1.4

27.8

1725

13413

K58

ICD-10 Finland

Irritable bowel syndrome

2.4

27.7

191

807

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.2

27.7

233

1073

UJF30

NOMESCO Finland

Ileoscopy through colon

1.6

27.4

666

4291

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.7

27.4

508

3052

Z71.9

ICD-10 Finland

Counselling, unspecified

1.7

27.3

526

3194

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

2.1

27.2

274

1353

SDA04

NOMESCO Finland

Demanding periodontal treatment

1.4

27.1

1780

13953

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.4

27.1

2142

17288

H02AB07

ATC

prednisone; oral

1.5

27.1

806

5442

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.5

27.0

905

6269

N06AG02

ATC

moclobemide; oral

2.1

26.9

276

1372

J01DA01

ATC

[U] cefalexin

1.3

26.9

3752

32880

D12

ICPC

Constipation

2.1

26.8

257

1245

A08

ICPC

Swelling

1.8

26.7

387

2162

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

1.9

26.7

344

1851

Z00.0

ICD-10 Finland

General medical examination

1.5

26.7

1159

8451

H93.1

ICD-10 Finland

Tinnitus

1.8

26.7

445

2593

N06BA12

ATC

lisdexamfetamine; oral

3.7

26.7

229

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

3.0

26.7

120

409

Z3226

NOMESCO Finland

Physiotherapist

1.5

26.6

1063

7627

WZC00

NOMESCO Finland

Treatment plan or consultation

1.3

26.6

2284

18652

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.6

26.6

689

4508

SPAT1058

SPAT

PEF monitoring instruction

1.7

26.5

505

3055

H81

ICPC

Excessive ear wax

1.5

26.5

1049

7514

WX722

NOMESCO Finland

PEEP

2.1

26.5

271

1346

S06.0

ICD-10 Finland

Concussion

1.6

26.4

648

4183

XF402

NOMESCO Finland

ECG with work load test

1.6

26.2

612

3904

R06AE09

ATC

levocetirizine; oral

1.5

26.2

876

6064

N40

ICD-10 Finland

Hyperplasia of prostate

1.5

26.1

939

6596

IAB01

NOMESCO Finland

Psychiatric pharmacotherapy consultation

3.8

26.0

210

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.4

26.0

1132

8254

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

2.2

25.9

215

985

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.0

25.8

267

1331

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.5

25.7

821

5626

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.4

25.7

1888

15044

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

2.0

25.6

277

1404

K07.60

ICD-10 Finland

Snapping jaw

1.9

25.6

340

1848

D07AD01

ATC

clobetasol; topical

1.5

25.6

1047

7543

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.4

25.5

1338

10087

M47.82

ICD-10 Finland

Other spondylosis, cervical region

2.0

25.2

273

1384

J34.2

ICD-10 Finland

Deviated nasal septum

1.9

25.2

307

1622

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.1

25.2

259

1289

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.7

25.2

508

3121

S21

ICPC

Skin texture symptom/complaint

1.5

25.1

953

6763

J05AB01

ATC

aciclovir; systemic

1.4

25.1

1349

10208

SPAT1254

SPAT

Administration of medicine

1.5

25.1

854

5930

N04AA02

ATC

biperiden; systemic

2.8

25.0

125

451

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

2.5

25.0

163

672

R50.9

ICD-10 Finland

Fever, unspecified

1.5

25.0

883

6178

A03CA02

ATC

clidinium and psycholeptics; oral

1.9

24.9

349

1931

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.5

24.8

793

5431

J45.1

ICD-10 Finland

Nonallergic asthma

1.7

24.8

431

2540

F61.0

ICD-10 Finland

Mixed personality disorders

2.9

24.8

118

415

SPAT1053

SPAT

Memory test

1.5

24.8

795

5450

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

2.8

24.8

122

437

S02

ICPC

Pruritus

2.1

24.8

240

1168

L60.0

ICD-10 Finland

Ingrowing nail

1.9

24.7

306

1626

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

2.4

24.7

171

725

C05AA08

ATC

fluocortolone; rectal, topical

1.5

24.6

795

5460

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.5

24.5

754

5121

R05FA02

ATC

opium derivatives and expectorants; systemic

1.3

24.4

2356

19510

M15

ICD-10 Finland

Polyarthrosis

1.8

24.3

350

1952

Z01.9

ICD-10 Finland

Special examination, unspecified

1.8

24.3

389

2240

M77.4

ICD-10 Finland

Metatarsalgia

1.8

24.3

401

2330

M03AX01

ATC

botulinum toxin; parenteral

3.0

24.3

104

345

G25.3

ICD-10 Finland

Myoclonus

7.9

24.2

I10

ICD-10 Finland

Essential (primary) hypertension

1.3

24.2

3671

32312

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

2.7

24.2

129

482

R4110

NOMESCO Finland

Physiotherapy

1.4

24.2

1652

12990

H29

ICPC

Ear symptom/complaint other

1.5

24.2

764

5219

H02

ICPC

Hearing complaint

1.5

24.2

896

6327

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.2

24.0

210

983

R15

ICD-10 Finland

Faecal incontinence

2.2

23.9

209

978

R01BA52

ATC

pseudoephedrine, combinations; oral

1.3

23.9

1809

14449

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

1.7

23.8

426

2532

331

Kela drug reimbursment

Atomoxetine, dexamphetamine, guanfacine and lisdexamphetamine

3.4

23.6

249

SBB10

NOMESCO Finland

Dental impressions

1.8

23.6

389

2260

SCA01

NOMESCO Finland

Preventive oral health care, short

1.4

23.5

1675

13248

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.5

23.4

787

5448

N95.1

ICD-10 Finland

Menopausal and female climacteric states

1.5

23.4

818

5708

ZXE00

NOMESCO Finland

One hour or less

1.3

23.3

2259

18680

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

1.9

23.3

312

1700

N02CC07

ATC

frovatriptan; oral

2.0

23.3

254

1291

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.6

23.3

644

4272

SFA40

NOMESCO Finland

Restoration involving the entire crown of the tooth

1.4

23.2

1322

10089

P25

ICPC

Phase of life problem adult

2.0

23.1

270

1406

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

2.3

23.1

168

728

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.9

23.1

313

1713

M01AX17

ATC

nimesulide; oral

1.4

23.1

1387

10675

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.8

23.0

326

1808

R55

ICD-10 Finland

Syncope and collapse

1.6

23.0

635

4208

H01

ICPC

Ear pain/earache

1.5

22.9

718

4894

JN3AD

NOMESCO Finland

Abdominal CT examination

1.5

22.9

798

5563

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.2

22.8

189

865

SPAT1229

SPAT

Assessment of need for aid

1.7

22.8

449

2739

M01AH02

ATC

rofecoxib; oral

1.5

22.8

737

5057

N76.0

ICD-10 Finland

Acute vaginitis

1.7

22.7

395

2329

J01FA06

ATC

roxithromycin; oral

1.3

22.7

2355

19640

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.6

22.7

647

4320

N02CC04

ATC

rizatriptan; oral

1.8

22.7

351

2001

SXC05

NOMESCO Finland

Other oral or dental procedure

1.7

22.6

396

2341

T83

ICPC

Overweight

2.4

22.5

157

668

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.1

22.4

202

956

D07AB08

ATC

desonide; topical

1.6

22.4

637

4251

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.6

22.3

626

4166

R32

ICD-10 Finland

Unspecified urinary incontinence

2.2

22.2

194

907

R83

ICPC

Respiratory infection other

1.4

22.2

1490

11660

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

2.2

22.2

194

908

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.9

22.1

293

1592

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.5

22.1

876

6261

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

1.7

22.0

399

2379

J02AC02

ATC

itraconazole; systemic

1.4

22.0

1049

7754

R01AD01

ATC

beclometasone; nasal

1.5

22.0

902

6486

F29

ICPC

Eye symptom/complaint other

1.5

21.9

655

4418

N05AF03

ATC

chlorprothixene; systemic

2.4

21.9

155

664

J34.3

ICD-10 Finland

Hypertrophy of nasal turbinates

2.5

21.8

138

562

Z2221

NOMESCO Finland

Medical doctor

1.3

21.7

1580

12509

IFB01

NOMESCO Finland

Electroconvulsive Therapy (ECT)

4.4

21.7

120

N04BC06

ATC

cabergoline; oral

4.6

21.7

112

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.4

21.6

1056

7837

M19.8

ICD-10 Finland

Other specified arthrosis

1.9

21.6

265

1403

J01CA08

ATC

pivmecillinam; oral

1.3

21.6

2615

22219

KMAK, ,

NOMESCO Finland

1.3

21.5

3049

26424

N04BD01

ATC

selegiline; oral

2.9

21.5

100

348

XQ800

NOMESCO Finland

Prick test

1.7

21.4

440

2714

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

2.7

21.4

113

421

N02AJ13

ATC

tramadol and paracetamol; systemic

2.3

21.4

158

690

K10.3

ICD-10 Finland

Alveolitis of jaws

1.9

21.3

297

1639

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.7

21.2

365

2145

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

2.9

21.1

335

A03FA02

ATC

cisapride; oral, rectal

1.7

21.1

430

2647

DHB50

NOMESCO Finland

Turbinoplasty

2.3

21.0

162

720

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.6

21.0

471

2972

G04BD09

ATC

trospium; oral

2.3

20.9

160

709

S04

ICPC

Lump/swelling localized

1.5

20.9

672

4604

GD1AA, ,

SPAT

1.4

20.7

958

7037

J01FA09

ATC

clarithromycin; systemic

1.3

20.7

1827

14859

M15.8

ICD-10 Finland

Other polyarthrosis

2.3

20.6

153

669

X59

ICD-10 Finland

Exposure to unspecified factor

1.4

20.6

1097

8259

C10AX09

ATC

ezetimibe; oral

1.4

20.5

975

7195

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.6

20.5

502

3235

ZXE10

NOMESCO Finland

More than one and less than three hours

1.3

20.4

2058

17033

N06AA10

ATC

nortriptyline; systemic

2.4

20.4

144

616

3007

Kela drug reimbursment

Erenumab and fremanezumab

2.9

20.4

320

E66

ICD-10 Finland

Obesity

1.8

20.4

336

1952

IBB03

NOMESCO Finland

Assessment of vocational rehabilitation needs in a mental health context

5.6

20.3

F43.1

ICD-10 Finland

Post-traumatic stress disorder

2.2

20.3

164

743

SPAT1307

SPAT

Psychosocial counselling and guidance

1.8

20.3

325

1871

H02AB04

ATC

methylprednisolone; systemic

1.4

20.3

842

6064

L19

ICPC

Muscle symptom/complaint NOS

2.1

20.3

198

968

K07

ICPC

Swollen ankles/oedema

1.8

20.2

302

1703

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

2.8

20.1

350

M43.1

ICD-10 Finland

Spondylolisthesis

1.9

20.1

252

1345

C10AC01

ATC

colestyramine; oral

2.1

20.1

183

871

K80

ICPC

Cardiac arrhythmia NOS

1.6

20.0

535

3517

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.4

20.0

1330

10368

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.3

20.0

1584

12673

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

2.9

20.0

313

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

3.1

20.0

276

A03

ICPC

Fever

1.4

19.9

985

7318

A05

ICPC

Feeling ill

1.7

19.9

343

2018

SDA02

NOMESCO Finland

Periodontal treatment, brief

1.3

19.9

2132

17779

XA420

NOMESCO Finland

Extensive sleep examination

3.3

19.7

227

D50

ICD-10 Finland

Iron deficiency anaemia

2.3

19.7

152

676

J30.10

ICD-10 Finland

Allergic rhinitis due to pollen

1.8

19.7

326

1896

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.5

19.7

773

5508

M75

ICD-10 Finland

Shoulder lesions

1.8

19.6

278

1543

IBA01, ,

SPAT

2.4

19.6

129

535

R39.1

ICD-10 Finland

Other difficulties with micturition

2.1

19.5

180

861

C03CA01

ATC

furosemide; systemic

1.3

19.5

1625

13089

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.4

19.5

1012

7579

L04

ICPC

Chest symptom/complaint

1.7

19.5

396

2435

JBC01

NOMESCO Finland

Laparoscopic gastro-oesophageal antireflux operation

2.5

19.5

118

471

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.6

19.4

542

3597

JDF11

NOMESCO Finland

Laparoscopic gastric bypass

2.6

19.4

110

425

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

1.8

19.4

299

1703

A29

ICPC

General symptom/complaint other

1.4

19.4

808

5821

NF1AA

NOMESCO Finland

Hip X-ray examination

1.6

19.4

540

3584

ZXA10

NOMESCO Finland

Bilateral

1.4

19.4

1047

7895

M54.3

ICD-10 Finland

Sciatica

1.7

19.3

371

2247

SXC06

NOMESCO Finland

Clinical work to produce sleep apnoea splint

4.5

19.3

106

G62.8

ICD-10 Finland

Other specified polyneuropathies

3.3

19.3

215

SPAT1215

SPAT

Assessment of need for medical rehabilitation

1.9

19.3

248

1334

A01AB09

ATC

miconazole; local oral

1.6

19.3

490

3184

G23.1

ICD-10 Finland

Progressive supranuclear ophthalmoplegia [Steele-Richardson-Olszewski]

8.4

19.2

M16.9

ICD-10 Finland

Coxarthrosis, unspecified

1.7

19.2

373

2266

C08CA13

ATC

lercanidipine; oral

1.4

19.2

846

6155

N89

ICPC

Migraine

2.0

19.2

212

1084

M94.0

ICD-10 Finland

Chondrocostal junction syndrome [Tietze]

2.2

19.1

161

743

S22.3

ICD-10 Finland

Fracture of rib

1.6

19.1

408

2541

G31.8

ICD-10 Finland

Other specified degenerative diseases of nervous system

4.5

19.1

103

SPAT1243

SPAT

Psychiatric/psychological examination

2.3

19.1

151

679

G43.3

ICD-10 Finland

Complicated migraine

2.5

19.0

118

476

AA400

NOMESCO Finland

Electroconvulsive therapy

3.6

19.0

169

SPAT1325

SPAT

Vaccination

1.3

19.0

1891

15596

P99

ICPC

Psychological disorders other

2.1

19.0

185

904

N30.9

ICD-10 Finland

Cystitis, unspecified

1.6

18.9

414

2594

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.4

18.9

1181

9109

N05AX08

ATC

risperidone; systemic

1.6

18.9

455

2919

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.6

18.9

459

2952

X58

ICD-10 Finland

Exposure to other specified factors

1.4

18.8

837

6098

G44.0

ICD-10 Finland

Cluster headache syndrome

3.1

18.8

260

N07CA01

ATC

betahistine; oral

1.6

18.7

419

2640

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.4

18.7

1006

7573

F33.0

ICD-10 Finland

Recurrent depressive disorder, current episode mild

3.1

18.6

261

EB1MA

NOMESCO Finland

Cephalometry with X-ray

2.5

18.6

118

481

G04BD04

ATC

oxybutynin; oral, transdermal

1.8

18.6

301

1738

R03BC03

ATC

nedocromil; inhalant

1.6

18.6

395

2456

K02.0

ICD-10 Finland

Caries limited to enamel

1.4

18.6

1143

8791

R33

ICD-10 Finland

Retention of urine

1.7

18.6

386

2386

M76.0

ICD-10 Finland

Gluteal tendinitis

2.2

18.6

158

732

UJD02

NOMESCO Finland

Gastroscopy

1.8

18.6

273

1533

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.4

18.5

748

5355

XF400

NOMESCO Finland

ECG with 12 standard connections

1.4

18.5

822

5989

J01CE02

ATC

phenoxymethylpenicillin; oral

1.3

18.4

4044

36656

E000001, ,

ATC

1.4

18.4

1106

8480

N06AB08

ATC

fluvoxamine; oral

2.2

18.4

162

762

E03

ICD-10 Finland

Other hypothyroidism

1.6

18.3

387

2403

R29

ICPC

Respiratory symptom/complaint other

1.6

18.3

407

2560

R30.1

ICD-10 Finland

Vesical tenesmus

2.2

18.3

146

659

D64.9

ICD-10 Finland

Anaemia, unspecified

1.5

18.3

600

4122

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

1.8

18.3

259

1438

G04CB01

ATC

finasteride; oral

1.6

18.3

437

2799

F60.9

ICD-10 Finland

Personality disorder, unspecified

2.9

18.2

302

G24.8

ICD-10 Finland

Other dystonia

5.6

18.2

F32.0

ICD-10 Finland

Mild depressive episode

2.1

18.2

170

818

R07.0

ICD-10 Finland

Pain in throat

1.6

18.1

425

2710

SPAT1283

SPAT

Restricted health certificate

1.4

18.1

889

6590

I50

ICD-10 Finland

Heart failure

2.1

18.0

165

787

R30.0

ICD-10 Finland

Dysuria

1.8

17.9

266

1498

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

2.4

17.9

120

503

ZYC01, ,

SPAT

1.5

17.8

607

4203

I95.1

ICD-10 Finland

Orthostatic hypotension

1.9

17.8

219

1163

H57.1

ICD-10 Finland

Ocular pain

1.8

17.7

245

1350

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

2.0

17.7

201

1038

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

2.4

17.7

119

499

N02CC06

ATC

eletriptan; oral

1.9

17.7

210

1101

IHZ04, ,

SPAT

2.5

17.7

107

427

R61.9

ICD-10 Finland

Hyperhidrosis, unspecified

2.7

17.7

352

C03DA01

ATC

spironolactone; oral

1.5

17.7

675

4780

EBA00

NOMESCO Finland

Extraction of tooth

1.3

17.6

2090

17587

SPAT1234

SPAT

Support of social functional capacity

1.7

17.6

293

1707

ACC51

NOMESCO Finland

Release of median nerve

1.6

17.6

454

2960

N02AA05

ATC

oxycodone; systemic

1.4

17.6

1018

7751

F48.0

ICD-10 Finland

Neurasthenia

5.7

17.6

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

1.3

17.5

1338

10621

SPAT1051

SPAT

Guidance regarding sleep disorders

2.6

17.5

100

388

L82

ICD-10 Finland

Seborrhoeic keratosis

1.4

17.5

1121

8674

J01MA06

ATC

norfloxacin; oral

1.4

17.4

746

5394

SPAT1211

SPAT

Application of soft bandage

1.5

17.4

493

3281

D03

ICPC

Heartburn

1.8

17.4

242

1337

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.4

17.3

822

6053

G54.0

ICD-10 Finland

Brachial plexus disorders

2.1

17.3

158

753

U71

ICPC

Cystitis/urinary infection other

1.6

17.3

442

2874

F51.2

ICD-10 Finland

Nonorganic disorder of the sleep-wake schedule

3.6

17.3

161

Z00.8

ICD-10 Finland

Other general examinations

1.6

17.3

463

3044

U01

ICPC

Dysuria/painful urination

1.5

17.3

497

3320

SPAT1070

SPAT

Doppler ultrasound examination of blood flow in arteries of lower extremity

2.5

17.3

109

444

N29

ICPC

Neurological sympt/complt other

2.3

17.3

125

542

E03.89

ICD-10 Finland

Other specified hypothyroidism

1.8

17.1

256

1446

XA421

NOMESCO Finland

Nocturnal polygraphy

4.0

17.1

117

F41.00

ICD-10 Finland

Moderate panic disorder

2.5

17.1

102

405

A01AB04

ATC

amphotericin B; local oral

1.8

17.0

260

1477

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.4

17.0

1037

7956

XKD06

NOMESCO Finland

Physiologic investigation of micturition

2.1

17.0

165

806

SPAT1377

SPAT

Polysomnography

2.0

16.9

190

978

T82

ICPC

Obesity

1.8

16.9

247

1385

WX408

NOMESCO Finland

General anesthesy, balanced

1.3

16.9

1442

11619

R06AX13

ATC

loratadine; oral

1.4

16.9

853

6349

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.5

16.9

543

3715

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

2.7

16.8

338

N03AF01

ATC

carbamazepine; oral, rectal

1.8

16.8

271

1564

NA1BG, ,

SPAT

2.3

16.7

120

518

A07EA06

ATC

budesonide; oral, local oral

1.9

16.7

219

1187

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.3

16.7

1376

11031

J01FF01

ATC

clindamycin; systemic

1.3

16.7

1534

12482

SPAT1043

SPAT

Audiometry

1.5

16.6

560

3867

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

16.6

1459

11797

G04BD11

ATC

fesoterodine; oral

2.0

16.6

170

847

ZXY01

NOMESCO Finland

Chief Physician, Head of Department or Deputy Chief Physician

3.8

16.6

133

R01AD05

ATC

budesonide; nasal

1.6

16.6

428

2791

-1, ,

NOMESCO Finland

1.3

16.5

1866

15578

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.3

16.5

1449

11714

U13

ICPC

Bladder symptom/complaint other

2.0

16.5

182

931

XKC03

NOMESCO Finland

Water cystometry

2.0

16.5

183

938

D02

ICPC

Abdominal pain epigastric

1.6

16.5

381

2420

L11

ICPC

Wrist symptom/complaint

1.5

16.5

562

3890

G04BD07

ATC

tolterodine; oral

1.8

16.5

272

1581

M01AX01

ATC

nabumetone; oral

1.8

16.5

235

1308

SPAT1212

SPAT

Extensive examination of musculoskeletal system

1.6

16.5

434

2843

F41.0

ICD-10 Finland

Panic disorder [episodic paroxysmal anxiety]

2.1

16.4

146

689

F40.1

ICD-10 Finland

Social phobias

2.2

16.4

134

611

F31.31

ICD-10 Finland

Bipolar disorder depressive episode with somatic syndrome

3.9

16.4

125

F33.8

ICD-10 Finland

Other recurrent depressive disorders

3.1

16.4

212

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.8

16.4

268

1554

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.4

16.3

962

7341

H13

ICPC

Plugged feeling ear

1.3

16.3

1107

8632

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.3

16.3

1103

8597

S22

ICPC

Nail symptom/complaint

1.6

16.2

392

2516

J01AA04

ATC

lymecycline; systemic

1.4

16.2

704

5102

WX002

NOMESCO Finland

Sedation and analgesia

1.3

16.2

1077

8368

AA1BG, ,

SPAT

2.2

16.1

134

616

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

2.6

16.1

340

F51.5

ICD-10 Finland

Nightmares

12.8

16.1

G03FA01

ATC

norethisterone and estrogen; systemic

1.4

16.1

828

6179

SDE03

NOMESCO Finland

Periodontal treatment by dental hygienist, extensive

1.3

16.1

1340

10752

WYA10

NOMESCO Finland

Emergency care or similar visit

1.6

16.0

414

2699

J30.4

ICD-10 Finland

Allergic rhinitis, unspecified

1.8

16.0

227

1261

P02

ICPC

Acute stress reaction

1.7

16.0

311

1892

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.5

15.9

606

4287

WW200, ,

SPAT

1.3

15.8

1748

14541

OAB42, ,

SPAT

1.4

15.8

742

5451

M54.8

ICD-10 Finland

Other dorsalgia

1.7

15.7

283

1685

E66.00

ICD-10 Finland

Metabolic syndrome

1.7

15.7

308

1876

K03.00

ICD-10 Finland

Approximal wear

1.5

15.7

448

2987

N07BB01

ATC

disulfiram; oral

1.9

15.6

210

1148

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.6

15.6

391

2533

M70.7

ICD-10 Finland

Other bursitis of hip

2.0

15.5

170

868

B80

ICPC

Iron deficiency anaemia

2.0

15.5

163

820

NA3BG, ,

SPAT

1.8

15.4

246

1416

M35.7

ICD-10 Finland

Hypermobility syndrome

2.5

15.4

395

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

1.7

15.4

266

1566

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

1.8

15.4

226

1269

C08CA05

ATC

nifedipine; systemic

1.7

15.4

309

1896

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

1.6

15.3

410

2695

L09

ICPC

Arm symptom/complaint

1.7

15.3

297

1805

IEY05, ,

SPAT

5.5

15.2

J01MA12

ATC

levofloxacin; systemic

1.3

15.2

987

7636

C08CA01

ATC

amlodipine; oral

1.2

15.2

2169

18575

ZXD10

NOMESCO Finland

Scheduled procedure

1.3

15.2

2130

18205

F32.01

ICD-10 Finland

Mild depressive episode with somatic syndrome

3.0

15.2

222

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

1.7

15.1

271

1612

IAA02, ,

SPAT

4.6

15.1

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

2.7

15.1

305

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.4

15.1

669

4864

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.5

15.1

503

3465

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

1.6

15.1

363

2329

IDY30, ,

NOMESCO Finland

45.1

15.0

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.5

15.0

547

3834

L29

ICD-10 Finland

Pruritus

2.5

15.0

394

K04.08

ICD-10 Finland

Other specified pulpit

1.5

15.0

427

2845

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

2.6

15.0

341

SHA04

NOMESCO Finland

Stomatognathic treatment, very demanding

2.6

15.0

341

R00.0

ICD-10 Finland

Tachycardia, unspecified

1.8

15.0

244

1414

C01DA14

ATC

isosorbide mononitrate; oral

1.4

14.9

736

5449

IGY99, ,

SPAT

2.4

14.9

104

444

F41.3

ICD-10 Finland

Other mixed anxiety disorders

2.5

14.9

366

R4120, ,

SPAT

2.5

14.9

390

C09CA01

ATC

losartan; oral

1.3

14.9

1456

11917

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

1.7

14.8

261

1545

OAB91, ,

SPAT

1.6

14.8

384

2505

ZA1.0

ICD-10 Finland

Shoulder region

2.1

14.8

144

704

NAG62

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, 2-3 vertebraea

2.2

14.8

124

572

H02.3

ICD-10 Finland

Blepharochalasis

1.6

14.8

382

2490

B37.0

ICD-10 Finland

Candidal stomatitis

2.7

14.8

297

R05FB02

ATC

cough suppressants and expectorants; systemic

1.2

14.8

2090

17865

L05

ICPC

Flank/axilla symptom/complaint

1.6

14.7

373

2421

R01AD59

ATC

mometasone, combinations; nasal

1.6

14.7

386

2526

SPAT1281

SPAT

Other administrative function

1.5

14.7

419

2793

R10.2

ICD-10 Finland

Pelvic and perineal pain

2.0

14.7

147

727

U04

ICPC

Incontinence urine

1.6

14.7

349

2233

K07.4

ICD-10 Finland

Malocclusion, unspecified

2.3

14.7

105

454

IFB02

NOMESCO Finland

Transcranial magnetic stimulation (TMS)

5.3

14.6

K02

ICD-10 Finland

Dental caries

1.6

14.6

377

2458

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.5

14.6

525

3671

K04.1

ICD-10 Finland

Necrosis of pulp

1.4

14.6

606

4354

OAB48, ,

SPAT

1.4

14.6

879

6722

EB1AA, ,

SPAT

1.6

14.6

365

2364

M13.9

ICD-10 Finland

Arthritis, unspecified

1.5

14.5

420

2808

J05AB11

ATC

valaciclovir; oral

1.4

14.5

844

6419

M19.9

ICD-10 Finland

Arthrosis, unspecified

1.7

14.5

255

1510

SFA00

NOMESCO Finland

Small restoration

1.4

14.5

801

6043

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

2.2

14.5

126

591

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.4

14.4

589

4219

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

1.6

14.4

316

1982

F31.1

ICD-10 Finland

Bipolar affective disorder, current episode manic without psychotic symptoms

3.1

14.4

197

XG474

NOMESCO Finland

Exhalation nntrogen oxide

2.0

14.4

150

753

G50.1

ICD-10 Finland

Atypical facial pain

2.2

14.4

117

534

D07AA02

ATC

hydrocortisone; topical

1.4

14.4

745

5561

K04.0

ICD-10 Finland

Pulpitis

1.5

14.4

489

3383

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

1.5

14.4

467

3201

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.7

14.3

252

1492

M01AB55

ATC

diclofenac, combinations; oral

1.6

14.3

362

2349

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.4

14.3

639

4650

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

2.8

14.3

241

R4120

NOMESCO Finland

Occupational therapy

1.6

14.2

365

2376

TDA90, ,

SPAT

1.5

14.2

390

2577

R49.08

ICD-10 Finland

Other specified dysphonia

2.1

14.2

141

695

N05

ICPC

Tingling fingers/feet/toes

2.6

14.2

315

R03AC13

ATC

formoterol; inhalant

1.7

14.2

278

1695

L18

ICPC

Muscle pain

1.7

14.2

249

1474

Z71

ICD-10 Finland

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1.8

14.1

201

1119

ABC56

NOMESCO Finland

Decompression of lumbar spinal canal and nerve roots

1.9

14.1

162

841

XKD03

NOMESCO Finland

Urethral pressure profilometry

2.1

14.1

135

657

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.6

14.1

305

1907

C01CA24

ATC

epinephrine; parenteral

1.6

14.1

345

2223

SGA01

NOMESCO Finland

Emergency treatment

1.3

14.1

889

6845

X15

ICPC

Vaginal symptom/complaint other

1.8

14.0

228

1321

TQW40, ,

SPAT

1.4

14.0

574

4113

R44.1

ICD-10 Finland

Visual hallucinations

3.8

14.0

107

M15.0

ICD-10 Finland

Primary generalized (osteo)arthrosis

1.9

14.0

187

1021

F31

ICD-10 Finland

Bipolar affective disorder

2.7

14.0

283

M77.1

ICD-10 Finland

Lateral epicondylitis

1.5

13.9

445

3038

SPAT1360

SPAT

Extensive global examination

1.6

13.9

372

2445

IGY02, ,

SPAT

2.4

13.9

384

IEY21

NOMESCO Finland

Other intensified psychiatric treatment

5.2

13.9

M50.3

ICD-10 Finland

Other cervical disc degeneration

2.0

13.9

140

695

Z2446

NOMESCO Finland

Social worker

1.6

13.9

334

2144

R03AK11

ATC

formoterol and fluticasone; inhalant

2.0

13.8

149

757

S40.0

ICD-10 Finland

Contusion of shoulder and upper arm

1.7

13.8

250

1493

R01AD11

ATC

triamcinolone; nasal

1.5

13.8

469

3244

L90

ICPC

Osteoarthrosis of knee

1.5

13.8

401

2686

H92.0

ICD-10 Finland

Otalgia

1.6

13.7

364

2388

SPAT1252

SPAT

Overall medication plan or its review

1.6

13.7

352

2292

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.4

13.7

719

5375

L99

ICPC

Musculoskeletal disease other

2.0

13.7

144

725

ZXA00

NOMESCO Finland

Right side

1.3

13.7

1420

11687

N07BA03

ATC

varenicline; oral

1.7

13.6

251

1506

J37.0

ICD-10 Finland

Chronic laryngitis

1.8

13.6

190

1052

J46

ICD-10 Finland

Status asthmaticus

1.9

13.6

174

937

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.3

13.6

1391

11429

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.5

13.6

440

3013

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

1.9

13.6

164

867

E29.1

ICD-10 Finland

Testicular hypofunction

2.8

13.5

232

M47.9

ICD-10 Finland

Spondylosis, unspecified

1.8

13.5

184

1012

N81.6

ICD-10 Finland

Rectocele

1.5

13.4

401

2700

F01

ICPC

Eye pain

1.9

13.4

173

934

K85

ICPC

Elevated blood pressure

1.3

13.4

962

7545

IAB01, ,

SPAT

3.6

13.4

120

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.5

13.3

374

2485

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.4

13.3

506

3577

R40.0

ICD-10 Finland

Somnolence

4.5

13.3

G04CA52

ATC

tamsulosin and dutasteride; systemic

1.5

13.2

407

2757

SPAT1097

SPAT

Recording of ECG

1.4

13.2

771

5861

IBZ02

NOMESCO Finland

Somatic assessment of psychiatric patient

3.9

13.2

R06.2

ICD-10 Finland

Wheezing

1.7

13.2

242

1450

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

1.4

13.2

582

4225

WZC30

NOMESCO Finland

Teaching

1.3

13.2

922

7200

K03.65

ICD-10 Finland

Deposits [accretions] on teeth betel

1.3

13.2

1216

9857

WX320

NOMESCO Finland

Spinalanesthesy

1.3

13.2

1392

11476

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.5

13.2

411

2793

N05AE05

ATC

lurasidone; oral

4.2

13.1

J01AA07

ATC

tetracycline; systemic

1.4

13.1

791

6045

R07.2

ICD-10 Finland

Precordial pain

2.1

13.1

123

595

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.4

13.0

551

3970

WZC30, ,

SPAT

1.5

13.0

484

3406

N02CD01

ATC

erenumab; parenteral

3.0

13.0

193

A10BJ02

ATC

liraglutide; parenteral

1.9

13.0

161

859

AA1CG, ,

SPAT

2.6

13.0

300

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.5

13.0

430

2959

L84

ICD-10 Finland

Corns and callosities

1.8

13.0

195

1105

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.5

13.0

380

2549

L02.9

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle, unspecified

1.8

12.9

180

996

SDA01

NOMESCO Finland

Periodontal treatment, very brief

1.3

12.9

1583

13275

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

2.2

12.9

103

467

ZXD20

NOMESCO Finland

Day surgery

1.4

12.9

683

5113

N05BA06

ATC

lorazepam; systemic, sublingual

1.6

12.8

265

1638

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.3

12.8

1584

13293

N41.1

ICD-10 Finland

Chronic prostatitis

2.2

12.8

109

507

K29

ICPC

Cardiovascular sympt/complt other

1.7

12.8

241

1454

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.5

12.8

426

2935

SDE02

NOMESCO Finland

Periodontal treatment by dental hygienist

1.3

12.8

1323

10878

L84

ICPC

Back syndrome without radiat pain

1.6

12.7

281

1766

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.6

12.7

259

1595

R49.03

ICD-10 Finland

Atrophic dysphonia

2.6

12.7

291

SPAT1203

SPAT

Injection therapy, other than intramuscular or subcutaneous

1.7

12.7

221

1305

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

2.1

12.7

111

523

N02CC03

ATC

zolmitriptan; nasal, oral

1.6

12.6

299

1911

T07

ICPC

Weight gain

2.3

12.6

433

F39

ICD-10 Finland

Unspecified mood [affective] disorder

2.2

12.6

102

465

A23

ICPC

Risk factor NOS

1.4

12.6

533

3840

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

1.8

12.6

188

1063

WX402

NOMESCO Finland

General anaesthesia

1.3

12.6

1254

10260

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.4

12.6

748

5703

NA3AA, ,

SPAT

1.7

12.6

228

1363

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.6

12.5

281

1773

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

1.4

12.5

615

4548

A02BA04

ATC

nizatidine; systemic

1.5

12.5

383

2595

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.4

12.5

719

5456

J30.3

ICD-10 Finland

Other allergic rhinitis

1.8

12.4

198

1141

M16

ICD-10 Finland

Coxarthrosis [arthrosis of hip]

1.6

12.4

284

1802

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

1.9

12.4

155

830

SPAT1104

SPAT

Monitoring of emergency patient

1.5

12.3

343

2275

N02CD03

ATC

fremanezumab; systemic

2.8

12.3

221

SGB10

NOMESCO Finland

Root filling of tooth with one root canal

1.4

12.3

659

4943

N92.6

ICD-10 Finland

Irregular menstruation, unspecified

1.5

12.3

334

2205

K03.80

ICD-10 Finland

Irradiated enamel

1.6

12.3

316

2061

R19.5

ICD-10 Finland

Other faecal abnormalities

2.1

12.2

110

524

R31

ICD-10 Finland

Unspecified haematuria

1.4

12.2

479

3406

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

1.7

12.2

242

1482

M01AH03

ATC

valdecoxib; oral

1.6

12.2

322

2113

M76.8

ICD-10 Finland

Other enthesopathies of lower limb, excluding foot

2.0

12.1

124

619

M77.9

ICD-10 Finland

Enthesopathy, unspecified

1.8

12.1

179

1009

N03AF02

ATC

oxcarbazepine; oral

1.8

12.1

172

958

C10AA01

ATC

simvastatin; oral

1.2

12.1

2196

19170

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

2.0

12.1

137

709

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

2.1

12.1

118

579

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

2.0

12.1

134

689

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.4

12.1

541

3938

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.4

12.0

515

3718

R49.01

ICD-10 Finland

Functional dysphonia

1.8

12.0

174

975

A07AA02

ATC

nystatin; oral

1.5

12.0

319

2094

G03DB01

ATC

dydrogesterone; oral

1.4

12.0

691

5239

G50.0

ICD-10 Finland

Trigeminal neuralgia

2.1

12.0

109

521

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.3

12.0

1106

8959

K04

ICPC

Palpitations/awareness of heart

1.6

11.9

306

1993

R1250, ,

SPAT

1.8

11.9

179

1015

D10AX03

ATC

azelaic acid; topical

1.5

11.9

353

2375

WVA30, ,

SPAT

1.5

11.9

357

2408

N04BA03

ATC

levodopa, decarboxylase inhibitor and COMT inhibitor; oral

2.7

11.9

220

S80.0

ICD-10 Finland

Contusion of knee

1.5

11.9

427

2986

S82

ICPC

Naevus/mole

1.3

11.8

802

6230

S09

ICPC

Infected finger/toe

1.8

11.8

177

1002

R04

ICPC

Breathing problem other

1.7

11.8

214

1279

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

1.8

11.8

186

1069

S16

ICPC

Bruise/contusion

1.8

11.8

173

974

M16.1

ICD-10 Finland

Other primary coxarthrosis

1.4

11.8

647

4871

DFF00

NOMESCO Finland

Pure tone audiometry

1.4

11.8

559

4110

M65.3

ICD-10 Finland

Trigger finger

1.6

11.8

268

1699

K13.79

ICD-10 Finland

Change in the oral mucosa UNS

1.8

11.7

175

990

J30.0

ICD-10 Finland

Vasomotor rhinitis

1.9

11.7

149

802

H60.8

ICD-10 Finland

Other otitis externa

1.8

11.7

173

976

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.5

11.7

414

2886

G44.8

ICD-10 Finland

Other specified headache syndromes

2.2

11.7

409

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.2

11.7

1848

15900

IBZ07

NOMESCO Finland

Neurological assessment in psychiatry

5.5

11.6

M20.1

ICD-10 Finland

Hallux valgus (acquired)

1.4

11.6

481

3453

H50.52

ICD-10 Finland

Exophoria

2.5

11.6

275

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

2.1

11.5

109

529

L91

ICPC

Osteoarthrosis other

2.0

11.5

125

638

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

1.8

11.5

175

996

L30

ICD-10 Finland

Other dermatitis

1.9

11.5

138

730

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

4.0

11.4

A48

ICPC

General and Unspecified, Clarification/discussion RFE/demand

1.5

11.4

342

2305

X72

ICPC

Genital candidiasis female

2.5

11.4

271

G43.8

ICD-10 Finland

Other migraine

2.2

11.4

433

N06BA09

ATC

atomoxetine; oral

4.0

11.4

SPAT1284

SPAT

Extensive health certificate

1.9

11.3

140

747

F32.8

ICD-10 Finland

Other depressive episodes

2.2

11.3

447

I73.0

ICD-10 Finland

Raynaud syndrome

2.2

11.3

454

B35.1

ICD-10 Finland

Tinea unguium

1.5

11.3

361

2468

R75

ICPC

Sinusitis acute/chronic

1.6

11.2

271

1741

M53.3

ICD-10 Finland

Sacrococcygeal disorders, not elsewhere classified

2.3

11.2

340

K44

ICD-10 Finland

Diaphragmatic hernia

2.8

11.2

204

ZXH06, ,

SPAT

1.6

11.2

269

1726

IAA01, ,

SPAT

3.0

11.2

161

B37.09

ICD-10 Finland

Unspecified candidal stomatitis

2.5

11.2

286

S14

ICPC

Burn/scald

1.7

11.2

187

1095

SGA02

NOMESCO Finland

Opening and preparing the root canals

1.3

11.1

675

5157

R09.1

ICD-10 Finland

Pleurisy

2.1

11.1

101

483

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

1.7

11.1

204

1224

NAG66

NOMESCO Finland

Posterior interbody fusion of lumbar spine, 2 vertebrae

2.9

11.1

183

D06BB03

ATC

aciclovir; topical

1.6

11.1

251

1588

D06BX01

ATC

metronidazole; topical

1.4

11.1

599

4495

R52.1

ICD-10 Finland

Chronic intractable pain

2.6

11.1

228

SFC92

NOMESCO Finland

Other complicated additional procedure necessary for restorative treatment

1.5

11.1

340

2303

UJD10, ,

SPAT

1.8

11.1

152

839

R07

ICPC

Sneezing/nasal congestion

1.5

11.1

346

2354

S93.2

ICD-10 Finland

Rupture of ligaments at ankle and foot level

2.2

11.1

406

K13.78

ICD-10 Finland

Other change in the oral mucosa

1.8

11.0

153

847

NH3AA, ,

SPAT

1.5

11.0

305

2022

X14

ICPC

Vaginal discharge

2.0

11.0

120

614

ZXA05

NOMESCO Finland

Left side

1.3

11.0

1290

10739

WX110, ,

SPAT

1.5

11.0

300

1984

K03.66

ICD-10 Finland

Tooth plaque

1.4

10.9

417

2949

EB1CA

NOMESCO Finland

Tooth X-ray additional picture

1.4

10.9

505

3695

L20

ICPC

Joint symptom/complaint NOS

1.6

10.9

220

1353

K04.09

ICD-10 Finland

Pulpit UNS

1.6

10.9

235

1470

A09

ICPC

Sweating problem

2.3

10.9

345

K29.7

ICD-10 Finland

Gastritis, unspecified

1.7

10.9

193

1148

L29.8

ICD-10 Finland

Other pruritus

2.2

10.9

383

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.3

10.9

660

5045

NAG41

NOMESCO Finland

Anterior fusion of cervical spine with fixation

3.5

10.8

103

K59.9

ICD-10 Finland

Functional intestinal disorder, unspecified

2.1

10.8

449

H10.9

ICD-10 Finland

Conjunctivitis, unspecified

1.5

10.8

379

2638

A02BX02

ATC

sucralfate; oral

1.7

10.8

197

1181

ICC01

NOMESCO Finland

Psychiatric treatment plan, transfer to psychiatric outpatient clinic

4.2

10.8

N06AX18

ATC

reboxetine; oral

2.4

10.8

285

F51.8

ICD-10 Finland

Other nonorganic sleep disorders

2.9

10.8

170

S61.0

ICD-10 Finland

Open wound of finger(s) without damage to nail

1.4

10.8

453

3262

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.2

10.7

1365

11464

IBA01

NOMESCO Finland

Diagnostic and symptom-mapping evaluation

2.2

10.7

418

EB1BI

NOMESCO Finland

Cone beam imaging of teeth and jaws (1–2 quarters)

2.0

10.7

107

531

XJH00

NOMESCO Finland

Transanal ultrasonography

1.6

10.7

236

1485

SPAT1238

SPAT

Brief therapy

2.2

10.7

412

R08

ICPC

Nose symptom/complaint other

1.7

10.7

197

1185

DAX08

NOMESCO Finland

Fitting of hearing aid

1.5

10.6

301

2005

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.5

10.6

348

2389

SPAT1237

SPAT

Psychotherapy

3.2

10.6

124

UJF30, ,

SPAT

2.6

10.6

239

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.5

10.6

372

2589

D10

ICPC

Vomiting

1.5

10.6

295

1958

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

1.5

10.6

313

2105

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.5

10.6

348

2392

M79.8

ICD-10 Finland

Other specified soft tissue disorders

3.1

10.6

140

S94

ICPC

Ingrowing nail

2.1

10.6

460

D01BA02

ATC

terbinafine; oral

1.2

10.6

1338

11229

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

1.6

10.5

249

1593

B35.3

ICD-10 Finland

Tinea pedis

1.6

10.5

241

1530

K07.63

ICD-10 Finland

Pain in the jaw joint UNS

2.0

10.5

118

610

R61

ICD-10 Finland

Hyperhidrosis

2.5

10.5

270

ICB02

NOMESCO Finland

Psychiatric treatment plan, extended/prolonged

2.6

10.5

229

M23

ICD-10 Finland

Internal derangement of knee

1.9

10.5

134

724

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.2

10.4

1705

14686

SCA02

NOMESCO Finland

Preventive oral health care

1.4

10.4

516

3819

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.4

10.4

531

3949

D50.8

ICD-10 Finland

Other iron deficiency anaemias

2.1

10.4

436

OAB72, ,

SPAT

2.2

10.4

410

S20.2

ICD-10 Finland

Contusion of thorax

1.5

10.4

274

1798

R20.8

ICD-10 Finland

Other and unspecified disturbances of skin sensation

2.4

10.4

290

KCV12

NOMESCO Finland

Urinary bladder endoscopic botulin therapy

2.5

10.4

248

R4190

NOMESCO Finland

Nutritional therapy

1.7

10.4

200

1217

G56.2

ICD-10 Finland

Lesion of ulnar nerve

1.7

10.4

176

1035

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.5

10.4

300

2009

N05CD02

ATC

nitrazepam; oral

2.2

10.4

372

IFA99

NOMESCO Finland

Other psychiatric pharmacotherapy service

3.0

10.3

147

AXX01, ,

SPAT

1.6

10.3

219

1365

KCV04

NOMESCO Finland

Distension of bladder with fluid

2.6

10.3

225

I50.9

ICD-10 Finland

Heart failure, unspecified

1.3

10.3

651

5002

N94.1

ICD-10 Finland

Dyspareunia

2.3

10.3

328

N28

ICPC

Limited function/disability (N)

2.1

10.3

100

491

SPF00

NOMESCO Finland

Reparation of dental prosthesis without impressions

1.8

10.3

159

910

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

1.7

10.3

180

1067

M16.0

ICD-10 Finland

Primary coxarthrosis, bilateral

1.4

10.3

384

2705

B03BA03

ATC

hydroxocobalamin; parenteral

1.5

10.3

276

1818

D02AE01

ATC

carbamide; topical

1.5

10.3

324

2208

M51.9

ICD-10 Finland

Intervertebral disc disorder, unspecified

2.2

10.3

399

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

1.4

10.3

579

4376

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

1.7

10.3

186

1114

XF404

NOMESCO Finland

Ambulatory ECG

1.4

10.2

438

3163

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.5

10.2

297

1990

K11.70

ICD-10 Finland

Hypoptyalism

3.0

10.2

148

A27

ICPC

Fear of other disease NOS

1.5

10.2

281

1861

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

1.6

10.2

261

1701

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.3

10.2

657

5064

U07.2

ICD-10 Finland

COVID-19, virus not identified

1.3

10.2

1018

8311

DJD20

NOMESCO Finland

Plastic repair of septum of nose

1.7

10.2

170

995

C10AA04

ATC

fluvastatin; oral

1.4

10.2

423

3040

T79.3

ICD-10 Finland

Post-traumatic wound infection, not elsewhere classified

2.2

10.2

388

Z73.0

ICD-10 Finland

Burn-out

1.6

10.2

204

1255

A10BK03

ATC

empagliflozin; oral

1.4

10.1

532

3975

WX290, ,

SPAT

1.7

10.1

174

1027

J02.9

ICD-10 Finland

Acute pharyngitis, unspecified

1.5

10.1

272

1793

L10

ICPC

Elbow symptom/complaint

1.5

10.1

291

1948

SCA04

NOMESCO Finland

Guidance on care of mouth and oral mucosa

4.2

10.1

ZYC05

NOMESCO Finland

Non-real-time text-based remote communication

2.2

10.1

383

G01AA10

ATC

clindamycin; vaginal

1.3

10.1

805

6393

I83

ICD-10 Finland

Varicose veins of lower extremities

1.8

10.1

146

821

G24.3

ICD-10 Finland

Spasmodic torticollis

2.5

10.0

246

T90

ICPC

Diabetes non-insulin dependent

1.2

10.0

1282

10760

G25.2

ICD-10 Finland

Other specified forms of tremor

2.9

10.0

155

L57.4

ICD-10 Finland

Cutis laxa senilis

5.0

10.0

FN1AD

NOMESCO Finland

CT of coronary arteries

2.0

10.0

104

524

OAB44, ,

SPAT

1.4

10.0

533

3992

T78.4

ICD-10 Finland

Allergy, unspecified

1.6

10.0

238

1526

G03FB06

ATC

medroxyprogesterone and estrogen; systemic

1.4

10.0

476

3501

ACC19

NOMESCO Finland

Transcision of peripheral nerve: other or unspecified

2.7

10.0

183

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

1.5

10.0

317

2164

O99.3

ICD-10 Finland

Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

2.2

10.0

352

K03.28

ICD-10 Finland

Other erosion of teeth

1.8

10.0

140

779

H02AB02

ATC

dexamethasone; systemic

0.7

10.0

335

4762

SPA02

NOMESCO Finland

Preparation for dental prosthetics

1.7

10.0

179

1069

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.3

10.0

829

6615

SPF02

NOMESCO Finland

Impression for dental prosthesis repair, restricted

2.2

10.0

378

OAB74, ,

SPAT

2.3

10.0

302

B07.9

ICD-10 Finland

Verruca simplex

1.7

10.0

189

1146

I49.3

ICD-10 Finland

Ventricular premature depolarization

1.4

9.9

383

2716

I84.9

ICD-10 Finland

Unspecified hemorrhoids without complication

1.6

9.9

232

1482

EB4VA, ,

NOMESCO Finland

1.3

9.9

938

7608

OAB38, ,

SPAT

2.1

9.9

412

S83.6

ICD-10 Finland

Sprain and strain of other and unspecified parts of knee

1.5

9.9

280

1868

R68.88

ICD-10 Finland

Other specified general symptoms and signs, not elsewhere classified.

2.7

9.9

190

J01

ICD-10 Finland

Acute sinusitis

1.5

9.9

307

2088

A60

ICPC

General and Unspecified, Result test/procedure

1.6

9.8

228

1453

G57.6

ICD-10 Finland

Lesion of plantar nerve

1.9

9.8

122

654

R1250

NOMESCO Finland

Evaluation of functional capability

1.8

9.8

137

762

WZB00, ,

SPAT

1.4

9.8

469

3453

G47

ICD-10 Finland

Sleep disorders

4.4

9.8

J45.8

ICD-10 Finland

Mixed asthma

1.7

9.8

161

940

A06AX04

ATC

linaclotide; oral

3.5

9.7

UJH02

NOMESCO Finland

Anoscopy

1.6

9.7

210

1316

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.5

9.7

300

2037

G04CB02

ATC

dutasteride; oral

1.5

9.7

294

1988

M01AB01

ATC

indometacin; systemic, rectal

1.5

9.7

336

2335

J01CF05

ATC

flucloxacillin; systemic

1.4

9.7

368

2602

N02CC02

ATC

naratriptan; oral

2.0

9.7

101

510

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

1.4

9.7

450

3297

M18.0

ICD-10 Finland

Primary arthrosis of first carpometacarpal joints, bilateral

2.1

9.7

449

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

1.7

9.7

158

920

U08

ICPC

Urinary retention

2.0

9.7

483

A03FA01

ATC

metoclopramide; systemic, rectal

1.2

9.6

1240

10411

D18

ICPC

Change in faeces/bowel movements

1.8

9.6

149

854

H26.4

ICD-10 Finland

After-cataract

1.4

9.6

548

4148

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.4

9.6

390

2791

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

2.6

9.6

210

K07.69

ICD-10 Finland

Dislocation of the jaw joint UNS

2.1

9.6

417

H01.0

ICD-10 Finland

Blepharitis

1.4

9.6

367

2598

R23.3

ICD-10 Finland

Spontaneous ecchymoses

1.9

9.6

119

638

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

1.8

9.6

130

717

M19

ICD-10 Finland

Other arthrosis

1.8

9.5

128

703

D07XC01

ATC

betamethasone; topical

1.3

9.5

601

4617

K07.68

ICD-10 Finland

Other disorders of the jaw joint

2.7

9.5

182

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

1.5

9.5

316

2177

G03FB05

ATC

norethisterone and estrogen; systemic

1.3

9.5

602

4627

R19.4

ICD-10 Finland

Change in bowel habit

1.7

9.5

167

992

G21.1

ICD-10 Finland

Other drug-induced secondary parkinsonism

4.6

9.5

B01AF01

ATC

rivaroxaban; oral

1.3

9.5

663

5169

F61

ICD-10 Finland

Mixed and other personality disorders

3.8

9.5

F02.39*G20

ICD-10 Finland

Dementia in Parkinson's disease without information on additional symptoms

3.1

9.5

123

Z98.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3001122) Ferritin [Mass/volume] in Serum or Plasma

5237

29131

4.87

307.65

4.2

3.2

99.01

118.43

ug/l

10.43

4853

27287

(3021960) Folate [Moles/volume] in Serum or Plasma

3175

17611

2.55

294.13

1.9

1.7

20.23

20.50

nmol/l

0.40

2756

14945

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

4249

27158

2.59

288.03

2.6

2.1

100.04

96.79

pmol/l

3.88

2256

14145

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

2980

16205

2.53

285.82

2.7

2.4

2.58

2.82

mg/l

8.72

2558

14067

(3022948) Iron [Moles/volume] in Serum or Plasma

2172

10532

2.58

260.75

2.5

2.6

14.47

12.92

umol/l

17.40

1990

9822

(3004789) Transferrin [Mass/volume] in Serum or Plasma

2032

9814

2.55

243.18

2.5

2.6

2.42

2.33

g/l

10.01

1847

9073

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1824

9058

2.40

199.26

2.5

2.7

23.54

22.31

3.35

1659

8412

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

5625

44470

2.80

195.70

5.3

4.5

10.97

12.29

mm/h

12.46

5317

41743

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

3008

18897

2.09

178.97

2.4

2.2

179.52

203.61

u/l

0.97

2834

17885

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

5772

46861

2.85

178.55

5.9

4.6

14.75

14.77

pmol/l

0.18

5374

43227

(3015377) Calcium [Moles/volume] in Serum or Plasma

3253

21659

1.99

158.24

2.9

3.5

2.35

2.36

mmol/l

1.02

2916

19683

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

6289

54453

4.33

157.61

7.6

5.7

1.81

1.90

mu/l

9.10

5948

50664

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

4218

30929

2.01

153.06

6.7

7.3

1.22

mmol/l

0.40

3663

26754

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

3963

28526

1.98

150.60

2.8

2.5

79.55

77.89

nmol/l

3.29

3611

25948

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

5595

45883

2.45

148.51

8.4

76.13

78.81

u/l

5.41

5338

43625

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

3806

27619

1.89

134.23

6.4

6.6

1.21

mmol/l

0.41

3533

25588

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

2324

14558

1.92

127.68

1.4

1.3

1.45

1.65

u/ml

0.29

636

3985

(3006315) Basophils [#/volume] in Blood

4132

31194

1.87

124.17

6.7

6.4

0.04

e9/l

0.20

3577

26735

(3013115) Eosinophils [#/volume] in Blood

4222

32118

1.87

123.51

6.9

6.6

0.19

e9/l

0.75

3724

28038

(3019309) Folate [Moles/volume] in Red Blood Cells

1769

10200

2.00

123.18

1.9

1.7

1176.55

1166.76

nmol/l

0.16

1346

7788

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1783

10315

2.00

122.95

2.6

3.4

0.83

0.82

mmol/l

8.27

1637

9715

(3037467) Urinalysis macro (dipstick) panel - Urine

5071

41066

2.02

121.55

5.5

4.8

1.61

2.62

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

3742

27512

1.83

121.15

4.5

5.0

36.42

35.71

g/l

13.81

3498

25804

(3001604) Monocytes [#/volume] in Blood

4109

31112

1.85

120.63

6.7

6.4

0.56

0.58

e9/l

5.94

3559

26666

(3019198) Lymphocytes [#/volume] in Blood

4176

31784

1.86

120.49

6.7

6.4

1.93

1.91

e9/l

0.36

3697

27947

(3031040) Bacteria [#/volume] in Urine by Automated count

4912

39568

1.95

116.44

6.1

4.9

667.62

2134.35

e6/l

2.50

508

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

6372

57529

4.17

110.44

20.0

16.2

20.60

23.57

mg/l

12.59

5488

47665

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

6151

54457

2.92

109.51

7.6

6.3

38.98

39.08

mmol/mol

0.42

5813

51075

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1945

11975

1.89

109.14

1.4

1.3

25.17

30.19

iu/ml

1.16

559

3667

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

2021

12807

1.83

102.16

1.8

1.7

14027328.25

32217583.25

pmol/l

1.16

1711

10721

(3021601) Nitrite [Presence] in Urine by Test strip

4116

32060

1.75

100.44

4.6

4.0

0.00

estimate

1.84

835

6694

(3015736) pH of Urine

3470

25804

1.73

99.71

4.0

3.6

6.24

0.07

1860

14404

(3013650) Neutrophils [#/volume] in Blood by Automated count

4388

34866

1.77

99.23

8.9

9.8

4.04

4.09

e9/l

0.79

3839

30225

(3035350) Ketones [Presence] in Urine by Test strip

4144

32425

1.75

98.60

4.6

4.1

0.00

3.82

estimate

4.35

843

6870

(3009261) Glucose [Presence] in Urine by Test strip

4164

32661

1.75

97.84

4.6

4.1

0.01

0.22

estimate

0.71

804

6493

(3019550) Sodium [Moles/volume] in Serum or Plasma

6400

58525

4.15

96.55

23.4

18.9

139.61

139.68

mmol/l

1.52

6323

57474

(3007164) IgA [Mass/volume] in Serum or Plasma

1976

12629

1.81

95.93

1.6

1.5

2.22

2.39

g/l

4.35

1178

7806

(3023103) Potassium [Moles/volume] in Serum or Plasma

6406

58646

4.20

95.83

23.7

19.1

3.97

3.96

mmol/l

0.50

6330

57486

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

4849

39874

1.82

95.26

3.9

3.3

43.21

46.32

u/l

1.73

4560

37495

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

6182

55514

2.81

94.76

6.3

5.2

5.88

5.90

mmol/l

0.88

5777

51210

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1946

12443

1.80

93.96

2.7

3.0

2.44

2.45

mmol/l

7.64

1736

11174

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1780

11133

1.82

92.19

1.4

1.3

9.45

11.73

u/ml

0.73

669

4402

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

6164

55444

2.71

90.92

19.0

15.7

81.00

80.97

ml/min/173m2

0.05

5830

51403

(3006504) Eosinophils/Leukocytes in Blood

3716

28591

1.69

90.26

6.8

6.6

2.92

2.83

1.74

3466

26797

(3022096) Basophils/Leukocytes in Blood

3714

28597

1.68

89.72

6.8

6.7

0.71

0.68

1.81

3468

26768

(3019069) Monocytes/Leukocytes in Blood

3719

28647

1.68

89.69

6.9

6.7

8.62

8.80

4.28

3475

26861

(40768797) Stomach Pathology biopsy report

1472

8748

1.88

89.44

1.3

1.2

—

(3002030) Lymphocytes/Leukocytes in Blood

3771

29300

1.67

86.62

6.8

6.6

28.45

27.84

2.95

3552

27755

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

4037

31952

1.68

86.12

5.5

6.6

10.39

11.25

umol/l

4.73

3812

30487

(3018010) Neutrophils/Leukocytes in Blood

3714

28794

1.66

85.58

6.7

6.5

56.75

57.32

2.40

3533

27486

(1002224) Polysomnography panel

633

2793

2.40

84.35

1.1

—

(3048689) Calprotectin [Mass/mass] in Stool

1378

8178

1.87

83.36

2.2

2.3

122.26

132.22

ug/g

0.51

1076

6492

(3013826) Glucose [Moles/volume] in Serum or Plasma

4360

35369

1.69

83.12

5.4

5.0

6.48

6.66

mmol/l

7.62

4173

33471

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1197

6814

1.92

82.22

1.9

1.7

1.45

0.13

1069

6013

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

3039

22555

1.64

81.74

4.5

3.8

198.66

52.88

ng/l

0.47

2070

15447

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2693

19456

1.65

80.09

2.8

2.7

56.24

63.91

u/l

1.13

2472

18023

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1076

6045

1.93

76.36

2.4

2.3

363.91

379.74

nmol/l

1.86

1010

5617

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

2031

13774

1.69

76.28

1.8

1.07

1.20

mg/l

0.80

1526

10711

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2500

17909

1.64

75.69

3.4

3.2

1117.19

1330.74

ng/l

1.25

2120

15455

(3018418) pH of Serum or Plasma

2600

18816

1.63

75.50

3.8

4.3

7.40

0.29

1786

13526

(3020564) Creatinine [Moles/volume] in Serum or Plasma

6499

60969

5.48

75.37

25.9

20.9

76.54

75.69

umol/l

1.20

6456

60297

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

6283

57847

2.82

73.60

6.8

5.8

2.69

2.73

mmol/l

3.54

5904

54032

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

786

4036

2.08

71.69

1.4

1.3

52.48

53.50

au/ml

0.04

277

(3018095) Leukocytes [#/volume] in Urine

3001

22702

1.59

71.12

4.5

4.0

90.26

100.71

e6/l

0.18

2163

15850

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

832

4381

2.03

70.79

2.6

2.4

24.96

22.09

au/ml

0.35

486

(3037522) Nuclear Ab [Titer] in Serum

1430

8963

1.76

70.67

1.5

1.4

583.58

539.34

titre

0.28

285

1973

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

6459

60603

4.17

69.14

14.7

12.3

25.37

25.57

u/l

0.47

6324

58939

(3026493) Urate [Moles/volume] in Serum or Plasma

2227

15792

1.62

68.51

2.6

2.7

333.80

336.28

umol/l

0.52

1940

13923

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

6200

57045

2.45

66.88

5.9

5.1

4.61

4.68

mmol/l

6.22

5839

53472

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

6168

56732

2.34

64.70

5.8

5.0

1.47

1.49

mmol/l

4.68

5780

52845

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

843

4641

1.94

62.64

1.5

1.4

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

5946

54107

2.00

61.32

4.9

4.3

1.30

1.28

mmol/l

2.43

5506

49904

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

472

2131

2.31

59.06

1.8

1.7

3.11

4.34

mg/l

2.12

409

1592

(3002582) Erythrocytes [#/volume] in Urine

2619

19808

1.53

58.29

3.7

3.4

45.55

75.93

e6/l

1.65

2033

15046

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

6532

62340

5.93

56.24

32.3

25.2

40.29

40.61

1.07

6496

61712

(3007461) Platelets [#/volume] in Blood

6531

62327

5.86

56.16

31.8

24.7

254.44

254.27

e9/l

0.07

6468

61163

(3024731) MCV [Entitic mean volume] in Red Blood Cells

6531

62335

5.84

55.97

31.7

24.6

91.22

91.12

1.26

6496

61737

(3035941) MCH [Entitic mass]

6531

62335

5.84

55.97

31.7

24.6

30.31

30.29

0.57

6496

61737

(3026361) Erythrocytes [#/volume] in Blood

6531

62341

5.83

55.83

31.8

24.7

4.45

4.46

e12/l

0.63

6449

60990

(3010813) Leukocytes [#/volume] in Blood

6531

62347

5.82

55.70

31.8

24.8

6.74

6.71

e9/l

0.47

6453

60987

(3000963) Hemoglobin [Mass/volume] in Blood

6531

62352

5.81

55.58

32.1

24.9

134.01

134.24

g/l

0.70

6496

61772

(40760892) CBC W Ordered Manual Differential panel - Blood

1921

13746

1.56

53.96

4.6

4.7

—

(36304419) Bacteria [Presence] in Urine

2208

16349

1.53

52.83

3.5

3.2

0.00

238.67

estimate

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

502

2432

2.15

52.73

1.5

1.7

0.22

0.31

mg/l

3.47

208

1098

(3030467) Casts [#/volume] in Urine by Automated count

2293

17168

1.51

51.81

3.5

3.3

0.29

0.42

e6/l

3.24

1705

12553

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

4305

36609

1.51

51.69

3.3

3.0

—

(3032080) INR in Blood by Coagulation assay

3382

27453

1.48

50.84

15.2

14.8

1.21

1.24

inr

2.70

2793

22900

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2639

20410

1.49

50.56

3.2

3.3

29.85

34.53

u/l

3.60

2472

19283

(3044889) 12 lead EKG panel

4717

41032

1.53

49.59

4.7

4.1

0.30

4905.55

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

2028

14928

1.52

49.04

4.5

3.9

0.50

0.46

0.03

156

(3026008) Bacteria identified in Urine by Culture

2513

19402

1.48

47.75

3.6

3.3

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

3024

24205

1.46

47.67

4.5

4.0

0.02

0.36

estimate

1.49

694

5518

(3029937) Albumin [Presence] in Urine by Test strip

2326

17702

1.49

47.44

4.8

4.3

0.00

estimate

0.30

806

6239

(3028707) Methadone [Presence] in Urine by Screen method

250

935

2.74

46.57

2.3

2.7

—

(36660697) Celiac disease serology panel - Serum

847

5099

1.76

46.32

1.2

—

(3000850) Epithelial cells [#/volume] in Urine

1872

13724

1.51

45.42

2.8

2.7

5.95

6.11

e6/l

0.11

1715

12492

(3011288) Drugs identified in Urine by Screen method Nominal

339

1511

2.31

43.52

2.8

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

670

3840

1.83

43.07

3.0

2.3

12.82

12.84

nmol/l

0.02

611

3463

(3020961) Endomysium IgA Ab [Titer] in Serum

548

2949

1.94

42.85

1.2

1.1

300.88

144.75

titre

0.50

(3027945) Reticulocytes/Erythrocytes in Blood

1060

6965

1.62

41.31

2.5

2.6

1.71

1.80

2.73

913

6214

(3023420) DNA double strand Ab [Units/volume] in Serum

510

2716

1.95

41.08

1.6

1.9

6.07

6.82

iu/ml

0.26

108

671

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

322

1442

2.30

40.87

2.2

1.9

40.16

41.88

nmol/l

0.64

315

1400

(3009508) Creatinine [Moles/volume] in Urine

2620

20846

1.43

40.35

3.5

3.4

7.31

7.26

mmol/l

0.21

2192

17641

(3019225) pH of Specimen

917

5859

1.66

39.85

4.6

4.3

7.37

7.36

1.17

670

4170

(3022145) Colonoscopy Study observation

1062

7070

1.60

39.00

1.3

1.4

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

731

4454

1.72

37.86

1.2

1.3

—

(40768804) Tissue Pathology biopsy report

3024

24889

1.40

37.34

2.2

—

(3020630) Protein [Mass/volume] in Serum or Plasma

821

5192

1.66

36.94

2.0

2.7

67.03

66.33

g/l

2.16

750

4776

(3005322) IgE [Units/volume] in Serum or Plasma

678

4072

1.74

36.94

1.4

1.3

158.61

227.55

u/ml

1.65

635

3779

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

652

3893

1.75

36.23

3.2

3.7

5.17

5.16

kpa

0.08

616

3739

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

451

2408

1.94

35.96

1.6

25.77

16.11

u/ml

0.79

562

(3009343) pH of Capillary blood

632

3772

1.75

35.13

3.3

3.7

7.42

0.02

510

3141

(1001926) Buprenorphine [Presence] in Urine by Screen method

345

1692

2.10

34.88

2.1

—

(3013512) EKG study

2556

20617

1.39

34.76

4.1

3.7

0.22

0.78

—

(3021589) Normoblasts [#/volume] in Blood

3203

26816

1.38

34.67

12.5

11.6

0.00

e9/l

1.27

2621

21787

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

675

4126

1.71

34.40

3.4

4.49

4.47

pmol/l

0.24

601

3702

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1150

8013

1.53

34.07

4.8

6.0

1.03

1.04

mmol/l

0.26

1064

7460

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

3028

25168

1.38

34.04

2.0

1.9

1.38

1.35

mmol/l

1.07

2530

21205

(3017732) Neutrophils [#/volume] in Blood

1136

7905

1.53

33.84

2.8

3.2

4.21

4.57

e9/l

0.95

939

6864

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

250

1090

2.34

33.76

2.2

1.9

198.75

199.92

pmol/l

0.05

238

1026

(3014051) Protein [Presence] in Urine by Test strip

2214

17524

1.40

33.31

3.3

3.0

0.08

0.05

0.13

407

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1463

10797

1.46

32.40

3.3

2.9

1.06

1.17

e6/l

0.36

793

5674

(3016879) Cocaine [Presence] in Urine

382

2003

1.96

32.07

2.1

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1392

10199

1.46

31.96

2.0

1.9

—

(3044640) Blood type and Crossmatch panel - Blood

2461

19947

1.37

31.59

2.4

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

553

3273

1.75

31.55

1.5

1.4

25.89

29.11

iu/l

1.46

471

2826

(3023520) Reticulocytes [#/volume] in Blood

821

5392

1.60

31.41

2.6

68.30

69.74

e9/l

0.58

611

3924

(3000764) Benzodiazepines [Presence] in Urine

400

2151

1.92

31.15

2.1

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

460

2589

1.83

31.07

1.3

0.70

1.30

u/ml

0.51

223

(3021387) Prolactin [Units/volume] in Serum or Plasma

386

2054

1.93

31.02

1.8

1.7

292.15

298.83

mu/l

0.16

351

1859

(3000570) Elastase.pancreatic [Mass/mass] in Stool

372

1962

1.95

30.69

1.5

1.4

301.38

279.79

ug/g

1.18

227

1149

(3003327) Ova and parasites identified in Stool by Light microscopy

411

2243

1.89

30.60

1.9

1.7

—

(3027008) Opiates [Presence] in Urine

399

2163

1.90

30.32

2.1

2.0

—

(3028300) Cannabinoids [Presence] in Urine

400

2172

1.90

30.24

2.1

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

378

2020

1.92

29.99

1.3

39.42

38.62

u/ml

0.01

111

(3019150) Specific gravity of Urine by Refractometry

1828

14203

1.40

29.99

4.9

4.2

1.02

1.33

kg/l

1.04

1205

9515

(3022313) Gas panel - Capillary blood

460

2618

1.81

29.94

3.3

3.8

—

(3033658) Prothrombin time (PT) actual/Normal

1965

15501

1.38

29.27

4.2

4.1

91.83

90.66

1.25

1904

15171

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

313

1580

2.03

29.25

1.2

1.3

517.67

542.54

mg/l

0.16

297

1513

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

538

3229

1.73

29.14

1.1

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

543

3278

1.72

28.79

3.1

3.6

1.59

1.94

mmol/l

1.58

407

2448

(3027944) Amphetamines [Presence] in Urine

390

2137

1.88

28.65

2.1

2.0

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

687

4417

1.62

28.57

1.3

1.2

111.56

141.06

u/ml

1.11

265

1655

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

283

1390

2.08

28.49

1.2

3.74

3.76

mmol/l

0.12

269

1317

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

3311

28365

1.34

28.48

2.8

—

estimate

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

422

2396

1.81

27.66

2.0

2.4

2.73

2.92

g/l

3.64

379

2185

(3012516) Albumin [Mass/volume] in Urine

2377

19476

1.34

27.29

3.5

49.01

45.79

mg/l

0.19

1433

12182

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

177

4.16

27.27

1.2

1.3

121.78

124.99

nmol/l

0.06

129

(3023368) Bacteria identified in Blood by Culture

2056

16494

1.36

27.07

4.6

4.3

—

(3000494) Fungus identified in Specimen by Culture

1049

7488

1.48

27.02

1.5

—

(3005719) IgG [Mass/volume] in Serum or Plasma

730

4827

1.58

26.90

2.7

2.9

10.13

10.56

g/l

2.31

679

4459

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

348

1876

1.90

26.88

1.3

6.75

8.38

u/ml

0.28

280

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

347

1874

1.90

26.65

1.3

6.40

4.99

u/ml

0.16

174

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

369

2035

1.86

26.55

3.4

3.9

24.81

24.92

mmol/l

0.38

344

1870

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1903

15166

1.36

25.90

2.4

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

436

2549

1.76

25.86

2.0

2.3

7.15

7.46

g/l

3.51

392

2336

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

435

2545

1.76

25.74

2.0

2.3

3.49

3.68

g/l

2.24

393

2336

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1442

11001

1.40

25.67

1.7

1.6

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

435

2547

1.76

25.66

2.0

2.3

4.22

4.23

g/l

0.05

392

2335

(3041096) Erythrocytes [Presence] in Urine by Automated

2132

17307

1.34

25.63

3.7

3.4

0.12

0.25

estimate

0.52

695

5353

(3020682) Albumin/Creatinine [Ratio] in Urine

2393

19799

1.33

25.12

4.2

7.97

8.69

mg/mmol

0.26

1413

12114

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1522

11763

1.38

24.96

4.7

3.9

192.65

460.75

ng/l

1.82

1131

9052

(3026782) Osmolality of Urine

1504

11638

1.38

24.39

2.7

3.0

509.19

521.39

mosm/kgh2o

1.43

1304

10195

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

375

2140

1.80

24.14

1.9

2.2

244.77

622.70

ug/l

2.78

349

2026

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

685

4576

1.55

24.01

1.7

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

449

2703

1.71

23.97

1.8

2.0

39.57

39.86

u/l

0.13

396

2417

(40758558) Short blood count panel - Blood

2244

18494

1.32

23.88

6.1

6.4

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1038

7569

1.44

23.64

1.9

1.8

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

305

1643

1.90

23.61

1.2

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

267

1375

1.98

23.61

1.3

1.4

9.05

31.58

e6/l

2.48

182

1021

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

384

2222

1.77

23.58

1.3

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

306

1653

1.89

23.49

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

306

1660

1.88

23.18

1.2

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

432

2605

1.70

22.91

1.3

1.6

2.56

17.61

iu/ml

—

(3045414) Leukocytes [Presence] in Urine

855

6053

1.47

22.67

2.2

0.01

estimate

0.11

172

1236

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

991

7217

1.44

22.65

5.7

4.9

33.10

32.75

0.46

696

4779

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

267

1397

1.95

22.56

1.3

1.4

629.37

1287.06

e6/l

1.21

194

1101

(3025941) Bacteria identified in Stool by Culture

520

3305

1.62

22.50

1.3

1.2

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

343

1957

1.79

22.09

1.8

0.23

g/l

0.35

331

1860

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

849

6034

1.47

22.02

2.5

32.15

47.16

u/l

1.17

708

5075

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

110

398

2.79

21.98

1.1

6.34

12.28

nmol/l

0.38

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

376

2214

1.74

21.72

2.1

2.4

0.40

0.86

g/l

3.10

323

1907

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

336

1915

1.80

21.72

1.3

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

287

1562

1.88

21.53

1.4

10.23

11.54

u/l

0.78

222

1275

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1278

9802

1.38

21.53

3.4

3.1

3.46

3.03

e6/l

0.52

603

4669

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

287

1567

1.87

21.32

1.3

3.02

4.07

u/ml

0.19

100

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

115

433

2.69

21.30

1.1

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

279

1518

1.87

20.96

1.3

40.07

43.71

u/ml

0.14

158

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

713

4943

1.50

20.90

3.1

3.8

83.37

88.49

ng/l

0.92

625

4254

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

980

7244

1.41

20.45

2.3

2.7

5.51

8.04

umol/l

9.00

785

6315

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

345

2021

1.75

20.30

1.8

1.19

g/l

0.03

335

1923

(46235355) HIV 1 and 2 tests - Meaningful Use set

1368

10698

1.35

20.20

2.1

1.9

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

365

2187

1.71

19.81

2.0

2.3

9.73

10.16

g/l

1.12

320

1952

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

294

2.99

19.72

1.4

2.8

—

(3007853) Bacteria identified in Skin by Aerobe culture

965

7184

1.40

19.24

1.8

—

(3008898) HLA-B27 [Presence]

358

2159

1.70

18.97

1.1

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

275

1539

1.82

18.90

1.2

1.1

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

492

3216

1.57

18.86

2.5

2.4

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

117

475

2.49

18.64

1.2

38.53

40.27

mg/l

0.15

100

404

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

919

6821

1.40

18.60

7.8

6.8

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

760

5462

1.44

18.41

7.4

7.8

1.31

mmol/l

0.00

746

5363

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

686

4856

1.46

17.99

2.7

2.3

5.06

7.13

ug/l

4.22

586

4258

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

939

7039

1.39

17.87

3.5

4.4

233.54

242.57

u/l

1.45

875

6668

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

292

1697

1.75

17.68

1.3

1.5

17.08

14.25

iu/ml

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

315

1872

1.72

17.62

2.1

2.3

0.01

0.02

g/l

0.81

280

1684

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1189

9285

1.34

17.42

1.9

2.1

29.43

29.50

0.15

1152

9022

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

944

7114

1.38

17.37

2.0

1.9

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

305

1806

1.72

17.29

2.1

2.3

0.00

g/l

0.50

261

1580

(3024666) Lithium [Moles/volume] in Serum or Plasma

323

2.75

17.20

14.0

12.9

0.66

0.62

mmol/l

0.60

293

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

131

583

2.27

17.03

1.1

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

384

2.58

16.85

1.4

1.5

4.96

6.12

u/l

1.45

340

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

111

462

2.43

16.80

1.1

231.83

262.49

mg/l

1.06

100

407

(3023410) Appearance of Cerebral spinal fluid

135

617

2.21

16.47

1.5

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

177

902

1.99

16.22

1.3

0.58

3.84

nmol/l

0.79

171

870

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1374

11052

1.31

16.20

5.0

4.5

21.37

21.89

0.62

635

5374

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

283

1674

1.72

16.12

2.2

2.3

0.00

g/l

-0.00

259

1578

(3045424) Erythrocytes [Presence] in Urine

459

3065

1.53

15.98

2.2

0.10

0.28

estimate

0.29

134

966

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1671

13812

1.28

15.94

6.1

5.5

2.14

2.81

ug/l

2.55

1526

12505

(3024869) Neuronal Ab [Presence] in Serum

4.25

15.93

1.1

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

546

3785

1.48

15.88

1.8

1.7

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

551

3829

1.48

15.83

2.3

2.0

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

273

1608

1.73

15.79

1.1

2.23

7.31

eliau/ml

2.64

186

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

5126

48153

1.29

15.78

23.7

19.9

13.60

13.63

0.88

5091

47540

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

153

759

2.04

15.14

1.3

—

nmol/l

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

464

3148

1.51

14.99

2.2

1.9

—

(3028026) IgM [Mass/volume] in Serum or Plasma

541

3786

1.47

14.99

2.0

1.37

1.34

g/l

0.09

495

3495

(3042936) Bacteria identified in Isolate by Culture

1094

8623

1.32

14.79

2.0

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

177

932

1.92

14.79

1.3

0.58

0.29

nmol/l

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

157

795

2.00

14.69

6.6

5.6

380.26

360.22

umol/l

1.10

145

705

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

511

3552

1.48

14.65

3.7

3.9

24.64

24.31

mmol/l

1.75

503

3515

(3015235) Bicarbonate [Moles/volume] in Capillary blood

333

2111

1.61

14.54

2.5

3.0

25.06

24.89

mmol/l

0.40

327

2086

(3004716) Salmonella sp identified in Stool by Organism specific culture

432

2906

1.52

14.53

1.4

—

(3006653) Thiamine [Moles/volume] in Blood

320

2.58

14.28

1.3

142.39

132.75

nmol/l

1.13

320

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

160

824

1.97

14.28

1.3

1.4

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

155

794

1.98

14.05

1.3

0.18

0.21

nmol/l

0.52

123

627

(3000991) Gas panel - Venous blood

701

5213

1.39

13.82

8.8

9.1

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

671

4961

1.39

13.70

2.4

2.5

0.29

0.45

e6/l

2.47

631

4749

(4027681) Cerebrospinal fluid IgG ratio and IgG index

351

2.47

13.66

1.2

0.64

0.58

ratio

0.47

208

(3017143) Hepatitis C virus Ab [Presence] in Serum

891

6897

1.34

13.57

1.6

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1037

8209

1.31

13.49

3.7

3.2

0.67

0.78

ug/l

1.56

698

5375

(3014007) Fractional oxyhemoglobin in Arterial blood

556

3990

1.43

13.46

9.1

9.8

94.01

94.00

0.02

556

3977

(3019977) pH of Arterial blood

904

7022

1.33

13.44

7.2

7.9

7.42

0.75

477

3817

(3001019) Free T4 and TSH panel - Serum or Plasma

441

3034

1.49

13.31

1.9

1.7

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

291

1825

1.62

13.30

1.4

1.3

—

(3016502) Oxygen saturation in Arterial blood

813

6236

1.35

13.15

7.6

8.2

95.79

95.69

0.20

793

6014

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

154

807

1.93

13.10

1.3

1.4

—

(3003396) Base excess in Arterial blood by calculation

895

6971

1.33

13.04

7.2

7.8

0.86

1.00

mmol/l

0.51

769

5743

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

219

1286

1.73

12.87

1.2

1.1

3.27

1.81

u/ml

0.87

116

678

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

354

2343

1.54

12.85

2.1

2.0

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

260

1600

1.65

12.82

1.2

3.16

4.14

1.06

206

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

302

2.53

12.80

1.4

166.75

191.32

pmol/l

0.33

302

(3024522) Salmonella sp identified in Specimen by Organism specific culture

154

815

1.91

12.73

1.3

1.4

—

(3042517) Benzodiazepines panel - Urine

5.11

12.66

2.4

2.7

—

(3027801) Oxygen [Partial pressure] in Arterial blood

897

7017

1.32

12.65

7.2

7.8

11.98

12.49

kpa

2.47

868

6747

(3049717) Cytology report of Urine Cyto stain

317

2055

1.57

12.62

2.4

2.6

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

897

7020

1.32

12.61

7.3

7.8

5.11

5.10

kpa

0.14

869

6751

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

780

5996

1.34

12.40

2.2

0.22

0.21

g/l

3.61

731

5614

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

351

2.38

12.25

1.1

1.0

1.00

1.16

u/l

2.22

153

(3002179) Metamyelocytes/Leukocytes in Blood

704

5339

1.36

12.23

4.0

4.3

0.62

0.68

0.26

202

1602

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

328

2161

1.54

12.16

2.0

1.8

—

(3025159) Blasts/Leukocytes in Blood

712

5421

1.35

12.05

4.4

4.7

0.05

0.33

1.83

173

1377

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

662

4994

1.36

11.89

3.3

3.9

1.23

mmol/l

0.98

545

4329

(3022621) pH of Urine by Test strip

658

4968

1.36

11.75

2.9

2.7

6.06

6.10

0.38

407

3348

(3023183) Ammonium ion [Moles/volume] in Plasma

209

1244

1.70

11.73

2.7

2.8

32.23

34.41

umol/l

0.69

187

1130

(3045683) HLA typing for celiac disease panel - Blood or Tissue

367

2.31

11.54

1.1

1.0

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

191

1115

1.73

11.50

1.1

6.06

4.76

u/ml

0.41

584

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

800

6239

1.32

11.48

2.6

2.1

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

733

5657

1.33

11.31

2.5

2.0

—

(3021440) Promyelocytes/Leukocytes in Blood

698

5359

1.34

11.15

4.2

4.6

0.19

0.11

0.85

166

1450

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

129

675

1.93

11.09

1.7

439.93

357.96

mu/l

0.64

107

531

(40761536) Microorganisms panel - Urine sediment

639

4857

1.35

10.91

4.3

4.1

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

432

3079

1.43

10.86

1.5

—

(4094501) Cardiovascular stress test using bicycle ergometer

257

1648

1.58

10.77

1.1

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

192

1148

1.69

10.63

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

192

1148

1.69

10.63

1.3

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

152

852

1.80

10.56

1.1

5.72

3.71

u/ml

0.50

368

(3021447) Carbon dioxide [Partial pressure] in Venous blood

772

6059

1.31

10.55

4.1

3.8

5.87

5.82

kpa

0.72

753

5900

(3004616) Nuclear Ab [Presence] in Serum

146

809

1.82

10.53

1.3

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

748

5847

1.32

10.52

7.9

8.6

121.52

120.75

g/l

0.50

736

5704

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

262

1698

1.57

10.49

1.9

2.1

11.34

11.84

mg/l

0.44

243

1585

(3017181) Myelocytes/Leukocytes in Blood

719

5596

1.32

10.43

4.2

4.5

1.00

0.88

0.42

186

1683

(3008401) Mugwort IgE Ab [Units/volume] in Serum

182

1080

1.70

10.37

1.1

1.14

0.98

u/ml

0.15

456

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

171

999

1.73

10.31

1.5

1.4

0.37

0.39

nmol/l

0.14

141

749

(3025468) Yersinia sp identified in Specimen by Organism specific culture

140

771

1.83

10.31

1.3

1.4

—

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

169

2.85

10.29

1.6

1.4

74.88

72.99

0.52

163

(3011985) Renin [Units/volume] in Plasma

156

890

1.77

10.22

1.6

1.5

99.58

56.73

mu/l

0.66

139

799

(3034860) Kappa light chains.free [Mass/volume] in Serum

311

2105

1.50

10.21

2.1

3.4

38.18

79.35

mg/l

0.95

274

1790

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

140

776

1.82

10.11

1.3

1.4

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

158

908

1.76

10.10

1.1

3.57

3.19

u/ml

0.11

444

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

310

2104

1.50

10.05

2.1

3.4

40.53

52.45

mg/l

0.58

274

1788

(3005988) Vibrio sp identified in Specimen by Organism specific culture

140

779

1.81

9.98

1.3

1.4

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

114

3.26

9.96

1.1

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

229

1461

1.59

9.84

1.9

2.3

131.83

128.06

g/l

1.53

165

1138

(3002032) Base excess in Venous blood by calculation

746

5882

1.30

9.83

4.2

3.8

1.93

1.87

mmol/l

0.18

681

5183

(3024139) IgG subclass 3 [Mass/volume] in Serum

122

654

1.88

9.80

1.7

1.3

0.36

0.40

g/l

1.05

469

(3027135) IgG subclass 1 [Mass/volume] in Serum

122

654

1.88

9.80

1.7

1.3

5.86

6.81

g/l

3.70

469

(3028192) IgG subclass 2 [Mass/volume] in Serum

122

655

1.88

9.76

1.7

1.3

2.71

2.93

g/l

0.83

473

(3037121) Protein [Mass/volume] in Urine

301

2044

1.50

9.74

3.1

278.96

452.02

mg/l

1.72

107

851

(3020717) Zinc [Moles/volume] in Serum or Plasma

382

2.16

9.72

1.3

1.4

26.39

22.80

umol/l

0.44

350

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

165

2.80

9.56

1.6

1.4

455.11

420.70

mu/l

0.09

159

(3010726) Horse dander IgE Ab [Units/volume] in Serum

171

1025

1.69

9.43

1.1

1.15

1.44

u/ml

0.29

500

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

182

1115

1.65

9.24

1.1

1.3

—

194.17

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

171

1031

1.68

9.23

1.1

9.10

15.98

au/ml

1.50

244

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

145

836

1.75

9.21

1.1

2.43

3.24

eliau/ml

0.32

367

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

131

733

1.80

9.21

2.0

2.1

16.46

22.38

mg/l

1.09

270

(3012544) pH of Venous blood

768

6142

1.28

9.05

4.1

3.8

7.38

0.47

401

3500

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

123

679

1.83

9.04

1.2

51.83

42.76

u/ml

—

(3020779) Urea [Moles/volume] in Serum or Plasma

685

5399

1.30

9.04

6.6

7.4

9.90

9.77

mmol/l

0.18

656

5183

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

528

4019

1.34

8.92

7.9

8.2

24.98

24.93

mmol/l

0.09

521

3997

(4062490) Immunoglobulin typing, IgG

117

640

1.84

8.87

1.7

1.4

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

390

2835

1.40

8.80

1.7

1.48

1.55

g/l

0.92

333

2445

(3024354) Oxygen [Partial pressure] in Venous blood

644

5053

1.30

8.78

3.4

3.2

4.58

4.54

kpa

0.28

625

4908

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

483

3638

1.35

8.75

9.3

9.8

24.29

24.35

mmol/l

0.15

472

3575

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1106

9263

1.23

8.73

1.7

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

278

2.28

8.57

1.2

1.6

29.18

29.56

umol/l

0.11

261

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

136

787

1.74

8.56

1.1

0.09

0.22

u/ml

1.74

254

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

141

825

1.72

8.53

1.6

1.3

343.27

346.91

pmol/l

0.03

123

700

(3020911) Cortisol [Moles/time] in 24 hour Urine

218

2.44

8.44

1.5

77.33

242.20

nmol/24h

0.69

218

(3002079) Sodium [Moles/time] in 24 hour Urine

264

2.28

8.23

1.3

163.34

157.06

mmol/24h

0.25

264

(3003740) Influenza virus B Ag [Presence] in Specimen

170

1057

1.62

8.19

1.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

145

868

1.69

8.10

1.3

1.2

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

141

838

1.70

8.09

1.3

67.76

57.28

u/ml

—

(3044927) Protein electrophoresis panel - Urine

108

597

1.82

7.96

1.2

1.1

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

167

1043

1.62

7.92

1.2

1.3

34.32

35.39

u/l

0.03

142

910

(3002523) Influenza virus A Ag [Presence] in Specimen

168

1056

1.61

7.76

1.1

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

488

1.90

7.73

1.1

1.0

284.58

293.05

mg/l

0.48

446

(3026389) Candida sp identified in Specimen by Organism specific culture

151

926

1.65

7.71

1.4

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

758

6170

1.26

7.70

1.4

1.5

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

169

1067

1.60

7.67

1.8

1.6

0.62

0.77

g/l

1.79

140

826

(3038177) Helicobacter pylori Ab [Presence] in Serum

163

1021

1.61

7.65

1.3

1.2

—

(3023511) Choriogonadotropin [Units/volume] in Urine

169

1069

1.60

7.62

1.6

1.3

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

261

1817

1.45

7.53

1.8

2.0

3.16

6.90

iu/l

0.66

767

(4146454) Self-monitoring of blood glucose

108

611

1.78

7.40

2.9

2.7

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

584

4645

1.28

7.18

1.4

—

(40768443) Skin Pathology biopsy report

379

2849

1.35

7.00

1.2

—

(4024509) Urine culture

395

2991

1.34

6.95

2.2

2.0

—

(3052851) Hemolysis interference index of Serum or Plasma

241

1680

1.45

6.93

3.2

2.02

1.91

index

0.11

126

859

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

171

1113

1.55

6.86

1.1

1.3

225.00

366.52

titre

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

263

1868

1.42

6.84

2.2

3.3

1.70

3.46

ratio

2.07

153

1082

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

5024

48266

1.17

6.78

26.4

20.7

331.85

331.78

g/l

0.20

5013

48011

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

234

1630

1.45

6.77

1.4

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

426

1.89

6.70

1.3

1.2

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

735

6055

1.24

6.70

3.5

3.4

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

280

2022

1.40

6.64

1.5

10.26

4.25

iu/ml

0.24

377

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

421

1.89

6.60

1.3

1.2

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

278

2.10

6.53

2.1

2.4

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

480

1.82

6.53

1.3

1.96

2.14

mmol/l

0.99

448

(3002256) Pathology report gross observation

973

8275

1.21

6.48

1.3

—

(3019832) Treponema pallidum Ab [Presence] in Serum

665

5440

1.25

6.45

1.9

1.8

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

135

2.60

6.44

1.4

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

455

1.83

6.37

1.1

10.60

9.41

iu/ml

0.09

128

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

392

1.90

6.32

2.3

2.4

472.94

510.22

e6/l

0.31

315

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

478

1.81

6.32

1.2

1.3

1.88

1.73

u/ml

0.07

275

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

582

4703

1.26

6.29

2.8

3.0

161.84

187.34

ng/l

1.18

529

4293

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

407

1.88

6.28

1.8

1.9

112.58

108.56

ng/l

0.09

407

(3025018) Bordetella pertussis Ab [Titer] in Serum

422

1.86

6.25

1.4

1.2

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

257

2.11

6.21

1.1

2351.50

328.60

ng/l

0.43

(4034850) Laboratory test

252

1812

1.41

6.15

12.7

10.0

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

134

848

1.59

6.11

1.1

1.82

2.78

0.67

136

(3038026) Centromere Ab [Units/volume] in Serum

492

1.78

6.05

1.3

1.2

91.60

66.42

u/ml

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

143

924

1.56

5.98

1.2

1.1

46.81

11913.99

iu/ml

0.54

197

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

400

1.86

5.96

2.4

2.5

215.70

218.33

e6/l

0.05

340

(3040151) Glucose [Moles/volume] in Capillary blood

111

675

1.66

5.95

3.0

4.5

7.78

7.34

mmol/l

0.30

571

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

272

1997

1.38

5.89

2.7

2.8

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

210

1474

1.44

5.88

1.9

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

410

1.84

5.84

1.0

270.87

327.11

ng/l

2.24

289

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1213

10610

1.18

5.83

1.6

1.5

—

(3000060) B lymphocytes [#/volume] in Blood

161

2.37

5.78

2.6

1.9

0.26

0.15

e9/l

0.62

(3017315) Amylase [Enzymatic activity/volume] in Urine

300

1.98

5.71

1.1

1.2

173.43

321.68

u/l

2.13

273

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

103

622

1.67

5.69

1.2

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

372

1.86

5.63

1.1

1.5

5.26

8.26

ug/l

2.95

332

(3000475) Leukocytes [#/volume] in Synovial fluid

217

1547

1.42

5.60

1.6

13174.02

11561.54

e6/l

0.25

163

1063

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

296

1.97

5.57

1.8

1.5

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

338

1.90

5.56

1.2

1.1

—

(3028626) Oxygen [Partial pressure] in Capillary blood

207

1467

1.42

5.53

3.1

3.2

8.38

8.15

kpa

1.28

200

1440

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

256

2.04

5.52

1.1

2.23

5.98

u/ml

—

(4198724) Urine methamphetamine measurement

236

2.08

5.51

2.4

2.6

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

411

1.81

5.50

1.0

788.65

741.35

ng/l

0.36

278

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

191

2.21

5.45

1.4

1.2

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

414

1.80

5.38

1.0

35.84

42.68

ng/l

1.36

288

(3003181) Sodium [Moles/volume] in Urine

170

1168

1.47

5.36

1.3

1.4

64.88

61.95

mmol/l

0.38

136

938

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

127

821

1.56

5.34

1.1

1.50

1.51

g/l

0.13

120

748

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

265

1972

1.36

5.31

1.5

1.3

—

(37208534) Antinuclear antibody arbitrary concentration in serum

203

2.13

5.11

1.1

—

(3010421) pH of Blood

262

1960

1.35

5.09

3.3

3.8

7.41

0.06

256

1940

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

153

1043

1.48

5.05

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

410

1.76

4.97

1.1

16.09

17.60

u/ml

0.22

176

(1616796) Gas panel - Central venous blood

188

1337

1.42

4.96

3.2

3.9

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

108

686

1.58

4.93

1.5

1.6

48.38

57.34

1.20

423

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.86

4.91

1.0

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

509

1.68

4.91

1.3

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

533

1.66

4.87

1.3

1.2

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

114

738

1.55

4.81

1.5

2.0

5.38

7.70

umol/l

0.96

538

(3008152) Bicarbonate [Moles/volume] in Arterial blood

452

3666

1.25

4.78

6.1

6.8

24.91

24.56

mmol/l

1.37

440

3499

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

189

2.12

4.77

1.0

14.66

11.13

u/ml

0.26

129

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

553

1.64

4.72

1.2

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

205

1494

1.38

4.72

1.3

1.2

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

114

742

1.55

4.70

1.1

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

532

1.64

4.66

1.3

1.2

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

434

1.71

4.63

1.4

1.5

10.90

12.29

umol/l

1.25

404

(40759836) Histone Ab [Presence] in Serum by Immunoblot

541

1.64

4.62

1.3

1.2

—

(3032057) Clostridioides difficile [Presence] in Stool

109

2.48

4.61

1.8

1.9

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

105

674

1.57

4.61

1.1

1.2

56.85

61.60

u/l

0.49

595

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

219

2.02

4.59

1.0

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

519

1.65

4.58

1.3

1.2

—

(3018333) Ribosomal P Ab [Presence] in Serum

497

1.66

4.55

1.3

1.2

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

283

1.88

4.53

1.3

1.7

1.91

1.98

umol/l

0.28

259

(3036489) Thrombin time

297

2305

1.30

4.50

1.7

2.0

20.74

20.91

0.23

270

2034

(1761868) Lipid panel - Serum or Plasma

2439

22703

1.12

4.48

3.2

3.1

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

244

1.93

4.38

1.3

1.2

—

(3021901) Oxygen saturation in Capillary blood

174

1252

1.40

4.35

2.7

3.1

91.01

89.94

1.54

165

1226

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

550

1.61

4.35

1.1

1.2

109.01

108.56

pmol/l

0.03

550

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

131

2.30

4.35

1.0

1.1

874.24

290.92

pmol/l

0.40

(3012501) Base excess in Blood by calculation

171

1231

1.40

4.27

3.4

4.2

2.35

2.63

mmol/l

0.84

113

848

(3013290) Carbon dioxide [Partial pressure] in Blood

171

1232

1.40

4.25

3.4

4.2

5.08

5.02

kpa

0.58

165

1211

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

618

1.56

4.20

1.6

1.5

—

(3011412) CD3 cells [#/volume] in Blood

579

1.58

4.19

2.5

2.3

1283.55

1176.88

e6/l

0.64

509

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

581

4906

1.20

4.18

2.5

2.7

67.82

66.59

ml/min/173m2

0.36

262

2075

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

207

1.99

4.15

3.3

2.5

119.33

152.93

nmol/l

1.74

181

(3027315) Oxygen [Partial pressure] in Blood

171

1239

1.39

4.12

3.4

4.2

8.84

8.58

kpa

1.16

165

1217

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

229

1.93

4.09

1.1

1.2

0.29

0.30

g/l

0.51

184

(1761482) Bacteria [#/volume] in Urine by Culture

1371

0.65

4.00

4.3

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

539

1.58

3.99

2.6

2.9

—

(3010838) Calcium [Moles/time] in 24 hour Urine

163

1182

1.39

3.93

1.9

5.41

4.97

mmol/24h

0.32

145

1048

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

369

2995

1.25

3.93

4.0

52.16

47.37

3.47

364

2943

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

164

2.08

3.90

1.1

54.93

58.36

u/ml

0.10

158

(40767503) Oxygen content in Capillary blood by calculation

172

1260

1.37

3.90

2.6

16.86

16.27

1.77

166

1235

(3000093) Morphology [Interpretation] in Blood Narrative

566

1.56

3.90

1.1

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

302

2397

1.27

3.89

2.0

1.9

1.28

2.11

ug/l

1.15

258

2124

(3003694) ABO and Rh group [Type] in Blood

1843

16994

1.12

3.89

1.5

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

296

2344

1.28

3.89

1.5

1.4

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

381

1.69

3.86

1.9

1.5

75.34

79.30

umol/l

0.53

381

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

390

1.67

3.81

1.4

1.5

8.00

6.29

u/l

0.45

319

(3008757) Leukocyte morphology finding [Identifier] in Blood

585

1.55

3.81

3.3

3.9

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

120

2.26

3.79

2.7

2.1

14.60

16.77

umol/l

0.65

120

(3024928) Oxygen saturation in Venous blood

203

1534

1.33

3.78

2.5

2.9

61.96

61.13

0.20

190

1494

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

246

1910

1.30

3.78

1.3

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

278

2193

1.28

3.78

2.7

2.2

4250.73

5345.29

u/l

0.25

104

884

(3006270) Folate [Moles/volume] in Blood

493

1.59

3.74

1.2

1.1

352.03

363.64

nmol/l

0.21

428

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

135

964

1.41

3.59

1.3

30.42

29.64

u/l

0.08

781

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

292

1.75

3.56

1.5

2.3

173.64

138.58

umol/l

0.24

160

(3010015) Selenium [Moles/volume] in Serum or Plasma

2.57

3.54

1.3

1.8

1.27

1.35

umol/l

0.37

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

158

1163

1.37

3.52

2.1

2.0

0.82

0.86

nmol/l

0.37

128

998

(3017354) Segmented neutrophils/Leukocytes in Blood

637

1.50

3.52

3.2

3.4

60.35

57.45

0.67

554

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

597

1.51

3.51

1.5

1.3

1.44

1.51

nmol/l

0.22

541

(3007463) Buprenorphine [Presence] in Urine

5.30

3.50

5.1

6.6

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

463

1.58

3.47

1.4

1.6

1.18

1.10

promille

0.18

362

(3015076) Soybean IgE Ab [Units/volume] in Serum

327

1.69

3.38

1.0

0.75

1.18

u/ml

0.18

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

112

785

1.43

3.33

1.6

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

134

2.09

3.32

1.2

—

(44813793) Dust mix specific IgE antibody measurement

429

1.59

3.32

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

337

1.67

3.30

1.2

1.1

—

(3048879) Bone marrow aspiration report

148

2.03

3.29

1.2

2.0

—

2.00

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

102

2.26

3.28

1.1

1.0

97.90

75.70

ug/l

1.36

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

330

1.67

3.28

1.1

1732.82

1485.65

miu/ml

0.87

330

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

2.30

3.26

1.9

2.0

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

256

1.76

3.24

1.5

1.8

40.23

39.79

g/l

0.18

256

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

233

1838

1.28

3.22

1.8

2.5

3.53

3.59

g/l

0.23

223

1755

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

402

1.60

3.20

1.8

1.5

—

(3020874) Milk IgE Ab [Units/volume] in Serum

371

1.62

3.19

1.1

10.89

1.98

u/ml

0.38

119

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

250

1.77

3.19

2.1

2.0

55.13

60.04

ug/l

0.27

244

(3007566) Smooth muscle Ab [Titer] in Serum

229

1807

1.28

3.16

1.2

65.71

149.94

titre

1.47

169

(3023419) Bacteria identified in Sputum by Culture

111

786

1.42

3.15

3.2

2.6

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

3.25

3.13

1.2

1.1

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

182

1397

1.31

3.11

1.4

1.7

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

3.43

3.10

1.1

—

(3034891) Synovial lining cells/cells in Synovial fluid

283

1.70

3.07

1.4

1.5

1.00

3.39

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

125

2.08

3.07

1.2

1.3

—

(3014271) Vancomycin [Susceptibility]

268

1.72

3.07

3.2

2.9

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

224

1.79

3.05

1.3

1.2

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

361

1.61

3.03

1.0

4.62

1.63

u/ml

0.34

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

611

1.46

2.99

1.1

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

147

1101

1.34

2.99

1.3

1.4

168.86

152.33

au/ml

0.71

313

(3033099) Centromere Ab [Titer] in Serum

148

1.96

2.94

1.2

1.1

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

549

1.48

2.91

1.4

77519.33

97823.30

e6/l

0.13

364

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

160

1220

1.32

2.89

1.3

1.4

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.37

2.88

1.0

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

199

1.81

2.88

2.7

2.8

26.04

28.72

umol/l

0.55

144

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

4.10

2.88

1.1

1.2

—

(3038515) Glucose [Moles/volume] in Venous blood

1195

0.69

2.87

3.4

3.2

6.85

7.53

mmol/l

1.59

1159

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

127

938

1.36

2.84

1.2

1.1

1.68

0.97

—

(3034770) Mitochondria Ab [Titer] in Serum

225

1799

1.26

2.83

1.2

562.00

902.24

titre

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

291

1.65

2.80

1.2

9.54

10.47

mm/h

0.29

291

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

221

1768

1.26

2.77

1.9

2.4

195.37

192.56

0.16

212

1688

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

202

1599

1.27

2.77

1.5

—

(3016038) Potassium [Moles/volume] in Urine

427

1.53

2.73

1.2

31.82

34.67

mmol/l

0.53

370

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

106

766

1.39

2.73

2.0

2.3

32.40

32.35

0.04

106

760

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

709

1.40

2.69

1.1

—

(3051611) Lipemic interference index of Serum or Plasma

584

1.44

2.68

3.1

3.3

16.75

13.31

index

1.13

330

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

195

1545

1.27

2.66

1.5

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

2.12

2.64

1.9

2.0

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

351

1.57

2.63

1.1

70.22

79.08

u/l

0.73

316

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

351

1.57

2.63

1.1

17.69

23.34

u/l

0.78

314

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

274

1.65

2.61

1.6

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

274

1.65

2.61

1.6

1.4

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

2.15

2.60

1.2

1.1

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

345

1.57

2.58

1.2

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

3.60

2.57

1.1

1.4

467.01

559.48

nmol/l

—

(3020650) Glucose [Presence] in Urine

207

1.74

2.56

1.7

1.8

0.00

0.06

estimate

1.34

207

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

491

1.47

2.55

1.2

83.00

175.27

titre

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

152

1179

1.30

2.48

1.4

—

(3031659) Enterovirus Ab [Titer] in Cerebral spinal fluid

4.38

2.47

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

180

1.78

2.46

1.2

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

180

1.78

2.46

1.2

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

180

1.78

2.46

1.2

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

180

1.78

2.46

1.2

1.1

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

136

1040

1.31

2.46

1.1

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

2.38

2.46

1.2

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

271

1.63

2.46

1.1

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

227

1860

1.23

2.35

1.2

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

314

1.56

2.34

1.4

1.3

5.26

4.65

umol/l

0.51

277

(3028717) Thiamine [Mass/volume] in Blood

2.04

2.31

1.1

1.2

55.05

64.57

ug/l

1.62

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

2.12

2.28

1.1

11.33

6.92

u/ml

0.39

(4015189) Microbial culture of sputum

148

1.83

2.28

2.2

2.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

504

1.43

2.27

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

504

1.43

2.27

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

504

1.43

2.27

1.5

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

234

1935

1.22

2.23

2.6

3.1

0.34

iu/ml

0.09

114

1061

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

121

925

1.31

2.23

1.3

1.2

4.55

4.63

u/ml

0.03

413

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

173

1386

1.25

2.21

1.4

—

(3025130) Human papilloma virus identified in Specimen

131

1014

1.30

2.21

1.8

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

230

1901

1.22

2.21

1.7

2.2

94.02

93.70

0.08

221

1841

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.13

2.18

1.0

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

492

1.43

2.17

1.0

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

129

999

1.30

2.17

1.6

1.7

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

2.16

2.14

1.2

107.17

65.20

ng/l

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

2.37

2.12

1.0

0.00

0.84

u/ml

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

2.37

2.12

1.0

0.00

0.09

u/ml

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

400

3487

1.16

2.09

9.3

10.1

16.10

15.93

0.59

390

3357

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

123

953

1.30

2.08

1.3

1.2

1.96

3.67

u/ml

2.11

339

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.26

2.07

1.1

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

398

1.46

2.06

1.1

1.2

60.31

90.54

u/l

4.21

340

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

702

1.34

2.06

2.2

2.0

20.25

25.79

ug/l

0.90

691

(3032352) Blasts [#/volume] in Cerebral spinal fluid

2.32

2.04

1.1

1.8

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

2.32

2.04

1.0

0.01

0.02

u/ml

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

146

1160

1.26

2.03

1.4

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

158

1268

1.25

2.02

1.5

1.6

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.11

2.02

1.3

1.4

—

(3004809) Band form neutrophils/Leukocytes in Blood

126

984

1.29

2.01

2.9

3.5

1.07

1.57

1.42

112

885

(44790047) Parainfluenza type 1 nucleic acid detection

102

775

1.32

2.00

1.2

1.4

—

(44790048) Parainfluenza type 2 nucleic acid detection

102

775

1.32

2.00

1.2

1.4

—

(44790049) Parainfluenza type 3 nucleic acid detection

102

775

1.32

2.00

1.2

1.4

—

(44806118) Parainfluenza type 4 nucleic acid detection

102

775

1.32

2.00

1.2

1.4

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

493

1.40

1.99

1.1

—

(3028271) Lactate [Moles/volume] in Capillary blood

122

951

1.29

1.98

2.0

1.9

1.63

1.66

mmol/l

0.17

116

925

(3020491) Glucose [Moles/volume] in Blood

418

1.44

1.98

2.3

2.1

6.77

6.56

mmol/l

0.26

290

(3018851) Theophylline [Moles/volume] in Serum or Plasma

2.28

1.97

2.2

1.6

37.23

44.86

umol/l

0.61

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

452

1.42

1.97

2.8

2.0

—

(3021367) Citalopram [Moles/volume] in Serum or Plasma

4.55

1.94

1.8

1.3

143.60

112.67

nmol/l

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

3.75

1.93

1.0

—

(3012565) Volume of 24 hour Urine

306

1.51

1.92

2.0

2.3

2079.00

1894.17

0.49

281

(3019230) Fractional oxyhemoglobin in Venous blood

163

1322

1.24

1.92

2.5

2.6

63.35

61.27

0.59

163

1315

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

113

1.86

1.91

2.2

8.15

7.39

mmol/l

0.30

(3041806) Other cells [#/volume] in Blood by Manual count

150

1.74

1.90

1.5

1.6

0.47

0.49

e9/l

0.12

150

(3017704) Immunofixation for Urine

316

1.49

1.87

1.1

1.5

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

576

1.36

1.86

1.6

—

(3035933) Granulocytes/Leukocytes in Blood

162

1318

1.23

1.86

2.9

3.3

57.24

58.02

0.38

162

1318

(3035320) C reactive protein [Mass/volume] in Body fluid

483

1.39

1.85

4.5

2.8

26.55

28.12

mg/l

0.12

342

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

750

1.31

1.85

1.5

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.98

1.84

2.3

1.6

—

(37021550) Renin [Units/volume] in Plasma --upright

122

1.81

1.83

1.1

1.3

84.31

70.53

mu/l

0.09

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

572

1.35

1.79

4.6

3.8

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

312

1.48

1.77

1.2

1.1

—

(3042631) Mycobacterium sp identified in Specimen

101

782

1.30

1.76

2.6

2.9

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

387

1.42

1.76

1.1

1.2

12.91

25.85

u/l

2.39

323

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

248

1.54

1.75

2.3

2.4

47.45

52.42

umol/l

0.41

218

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.90

1.75

2.3

2.2

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.93

1.74

1.7

1.6

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

627

1.33

1.73

1.5

1.6

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2.92

1.72

1.0

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

525

1.36

1.71

1.5

1.6

31.72

31.60

0.01

313

(3037756) Immunofixation for Serum or Plasma

155

1272

1.22

1.67

1.4

1.6

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

525

4745

1.12

1.62

1.8

1.7

3.40

3.50

mmol/l

1.39

357

3253

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

319

1.45

1.61

1.6

1.7

3.63

6.31

nmol/l

0.66

254

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

1.87

1.60

1.0

1.1

1.28

1.34

u/ml

0.01

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

2.69

1.58

7.1

4.9

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

490

1.35

1.57

1.4

1.5

16.63

21.95

u/ml

—

(3008295) Osmolality of Serum or Plasma

701

1.29

1.54

1.5

1.4

279.40

277.24

mosm/kgh2o

0.36

524

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

692

6364

1.10

1.54

2.1

2.0

3.41

3.45

ratio

0.42

515

4843

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

282

1.46

1.51

4.6

4.1

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.59

1.51

1.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

721

1.28

1.51

1.1

—

(3008037) Lactate [Moles/volume] in Venous blood

118

1453

0.81

1.51

3.1

1.56

mmol/l

0.00

118

1406

(3009677) Dengue virus Ab [Presence] in Serum

2.86

1.50

1.0

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

211

1805

1.17

1.49

2.9

3.1

1.43

1.54

mg/l

1.11

184

1651

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.90

1.49

1.2

1.1

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

1.95

1.48

1.1

1.0

0.00

0.43

u/ml

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

124

1.70

1.46

1.1

1.3

0.49

136.06

mg/l

1.48

(3039443) Prostate specific Ag panel - Serum or Plasma

760

1.27

1.46

1.8

1.6

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

2.22

1.46

2.2

2.6

—

(3045716) Anion gap in Serum or Plasma by calculation

663

1.29

1.46

1.8

3.1

10.10

10.57

mmol/l

0.54

652

(3022475) Manganese [Moles/volume] in Blood

2.37

1.45

1.0

1.4

0.17

0.16

umol/l

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

568

1.31

1.43

1.1

1.3

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

142

1177

1.21

1.43

1.2

309.81

271.72

u/ml

0.44

725

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

2.04

1.43

1.0

1.1

1.58

1.66

umol/24h

0.17

(3020123) Porphyrins [Interpretation] in Serum or Plasma

2.31

1.42

1.2

1.1

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

2.31

1.42

1.9

1.5

0.54

1.05

mg/l

—

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

2.31

1.42

1.9

1.5

2.26

4.28

mg/l

—

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

2.31

1.42

1.9

1.5

3.28

1.37

mg/l

—

(21494815) CD4 cells/Lymphocytes in Specimen

491

1.33

1.41

2.2

2.3

45.28

40.32

2.11

482

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

141

1.63

1.41

1.1

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

337

1.40

1.41

1.7

1.5

1.37

1.27

nmol/l

0.17

250

(3047181) Lactate [Moles/volume] in Blood

210

1807

1.17

1.40

4.5

6.1

1.30

1.29

mmol/l

0.03

191

1588

(3005033) Fetal Nuchal fold Thickness US

1081

0.79

1.35

1.5

1.25

1.27

0.13

766

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.14

1.33

1.1

—

(3041354) Potassium [Moles/volume] in Venous blood

628

0.73

1.33

2.4

2.3

3.97

4.03

mmol/l

0.47

618

(3035285) Chloride [Moles/volume] in Venous blood

628

0.73

1.33

2.4

2.3

106.04

105.38

mmol/l

0.46

618

(3004119) Hemoglobin [Mass/volume] in Venous blood

413

3732

1.11

1.33

3.1

131.08

128.89

g/l

1.31

401

3618

(3028679) Herpes simplex virus Ab [Presence] in Serum

333

1.38

1.32

1.2

1.1

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

719

1.26

1.30

1.3

1.5

2.58

3.83

ug/l

1.60

622

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

185

1.52

1.28

1.1

—

(3002619) Bacteria identified in Specimen by Culture

153

1.57

1.28

1.3

1.2

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

1.94

1.27

1.0

0.43

0.13

u/ml

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

107

1302

0.82

1.27

1.4

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

2.29

1.26

1.1

—

(4268621) Lupus anticoagulant assay

670

1.26

1.25

2.3

2.2

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.86

1.23

1.3

1.1

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

197

1709

1.16

1.22

2.0

1.7

—

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

2.16

1.21

1.0

0.01

3.96

u/ml

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

101

826

1.23

1.21

5.9

6.4

12.31

12.12

mg/l

0.19

775

(3047352) Trisomy 18 risk [Likelihood] in Fetus

1097

0.81

1.21

1.5

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

280

1.40

1.20

1.6

1.5

32.83

34.39

nmol/l

0.13

247

(3033705) Calcium.ionized [Moles/volume] in Venous blood

615

0.75

1.19

2.4

2.3

1.21

1.20

mmol/l

0.49

605

(3001964) Herpes simplex virus Ag [Presence] in Specimen

169

0.53

1.18

1.2

1.3

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.88

1.18

1.0

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

393

1.33

1.17

1.6

1.3

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

133

1.58

1.17

1.1

26.19

38.39

iu/ml

0.43

133

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

148

1262

1.18

1.15

3.7

5.2

2061.06

1842.56

iu/ml

0.04

162

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

110

1317

0.83

1.13

1.5

1.25

1.19

ratio

0.22

790

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

110

1317

0.83

1.13

1.5

0.97

0.94

ratio

0.24

786

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.85

1.13

1.1

1.0

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

110

1315

0.83

1.12

1.5

1.20

1.14

ratio

0.20

784

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

159

1.51

1.11

1.1

1.2

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

183

1592

1.15

1.11

1.3

1.2

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

209

1.44

1.10

1.2

1.1

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

172

1978

0.87

1.09

1.1

0.62

0.63

ratio

0.01

255

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

169

1.48

1.07

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

169

1.48

1.07

1.2

1.1

—

(3036071) Salmonella sp Ab [Titer] in Serum

194

1.45

1.06

1.0

1.1

—

(3028433) Virus identified in Specimen by Culture

178

1.46

1.05

1.3

1.2

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

220

1.41

1.04

1.2

1.5

13.67

15.19

pmol/l

0.99

186

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

2.27

1.03

1.0

2.83

1.51

u/ml

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

402

1.30

1.03

1.6

1.3

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

124

1056

1.18

1.01

1.6

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

163

1.47

1.01

1.1

1.0

—

(3000012) Reticulocyte production index

102

854

1.20

1.01

1.9

2.1

0.80

0.91

1.20

572

(3027273) Bicarbonate [Moles/volume] in Venous blood

291

2631

1.11

0.99

4.3

3.4

25.41

25.30

mmol/l

0.28

283

2540

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

1.71

0.98

1.1

1.2

71.15

70.66

ug/l

0.01

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

467

1.27

0.98

1.7

1.5

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

1.95

0.97

1.0

0.00

0.12

u/ml

—

(21494890) Protein electrophoresis panel - 24 hour Urine

603

1.23

0.97

1.3

2.0

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

1130

0.84

0.95

1.5

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

118

1009

1.17

0.94

2.1

2.6

116.83

1102.75

u/ml

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

125

1.52

0.93

1.0

1.1

0.73

0.68

umol/24h

0.26

(3017509) Phencyclidine [Presence] in Urine

1.82

0.92

3.3

1.3

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

167

1.44

0.91

1.1

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

159

1.45

0.91

1.0

1.1

8.64

1.92

u/ml

0.55

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

135

1.48

0.89

1.1

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.91

0.88

1.3

1.2

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

775

1.19

0.88

1.6

1.5

—

(3036670) Protein [Mass/volume] in Synovial fluid

177

1.41

0.88

1.3

1.2

40.04

38.80

g/l

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

803

1.19

0.88

1.2

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

1152

0.85

0.88

1.6

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

2.00

0.87

1.0

1.1

9.52

8.38

mmol/l

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

136

1.47

0.86

1.8

1.5

0.15

0.25

mmol/l

—

(3027035) Albumin [Mass/time] in 24 hour Urine

1.72

0.86

1.2

1.3

—

577.53

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

109

935

1.17

0.85

1.4

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

1.94

0.84

1.5

1.4

60.68

27.54

nmol/l

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

154

1.43

0.83

1.2

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

227

2052

1.11

0.82

1.5

—

(3047189) Immunofixation for 24 hour Urine

284

0.70

0.81

1.6

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

307

0.72

0.81

1.4

1.5

—

(40760410) HLA-B [Type] by High resolution

0.00

0.79

0.0

1.0

—

(40763590) HLA-DQ beta [Type]

0.00

0.79

0.0

1.0

—

(46236302) HLA-C [Type] by High resolution typing

0.00

0.79

0.0

1.0

—

(40760409) HLA-A [Type] by High resolution

0.00

0.79

0.0

1.0

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.82

0.79

1.0

—

(3013862) HLA-DP [Type]

0.00

0.79

0.0

1.0

—

(1617658) Protocol used for examination of sentinel lymph nodes

518

0.79

0.77

1.0

1.1

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

466

1.23

0.77

1.6

1.5

—

(21494814) CD8 cells/Lymphocytes in Specimen

252

1.31

0.76

2.1

29.27

30.24

0.13

252

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.70

0.75

1.0

1.1

9.11

15.43

u/l

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.67

0.74

2.7

2.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

307

1.27

0.73

1.3

1.5

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

307

1.27

0.73

1.3

1.5

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

2.00

0.72

1.0

1.5

—

(21494434) Karyotype in Bone marrow

506

1.21

0.72

1.2

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

272

1.29

0.72

1.9

1.7

2.12

3.29

u/field

0.45

189

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

607

1.19

0.72

5.0

5.5

97.19

86.81

u/ml

0.05

194

(44806071) Cardiolipin IgM antibody measurement

1.55

0.71

1.0

1.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.62

0.71

1.1

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

1.75

0.71

1.0

1.1

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

300

1.27

0.70

1.8

1.7

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

300

1.27

0.70

1.8

1.7

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

300

1.27

0.70

1.8

1.7

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

300

1.27

0.70

1.8

1.7

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

345

1.25

0.70

1.2

—

(44806420) Estimation of glomerular filtration rate

684

1.17

0.69

2.6

2.4

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

206

2260

0.91

0.68

2.9

3.5

133.43

2663.88

u/ml

1.34

178

1941

(40768806) Pleura Pathology biopsy report

607

0.82

0.68

1.5

1.6

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

266

1.28

0.68

1.7

1.9

2.05

1.82

u/ml

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

125

1409

0.88

0.68

1.4

1.5

62.09

59.70

ug/l

0.17

106

1166

(3038071) Oxygen [Partial pressure] in Mixed venous blood

120

0.58

0.67

2.4

7.5

7.24

5.46

kpa

—

120

(21494755) Public health laboratory ask at order entry panel

496

5251

0.94

0.67

1.3

—

(3024471) HLA-A [Type]

156

0.64

0.67

1.1

1.0

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.55

0.67

4.0

3.2

57.60

44.09

—

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

0.55

0.67

8.0

6.3

9.40

8.08

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.63

0.66

1.3

1.9

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

119

1.43

0.66

1.2

1.5

—

97.88

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

1.79

0.66

1.0

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

457

1.21

0.66

1.8

1.7

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

233

2534

0.92

0.65

4.5

5.3

0.89

0.88

0.15

222

2390

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

286

1.26

0.65

1.4

1.1

13.17

17.09

u/ml

—

(3024932) HLA-DR beta [Type]

153

0.65

0.62

1.1

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

1.67

0.61

1.0

1.1

0.57

1.18

mom

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

665

1.16

0.61

1.2

1.1

95.17

97.06

0.29

627

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.60

0.61

3.4

2.5

0.25

0.64

u/field

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.60

0.0

1.1

—

(3044009) aPTT.lupus sensitive (LA screen)

1.57

0.60

1.8

1.2

—

(21494227) Amikacin free [Mass/volume] in Serum or Plasma

0.00

0.59

0.0

4.9

—

3.36

—

(4281824) Cell count and differential, peritoneal fluid

747

0.86

0.59

1.2

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

185

0.70

0.58

1.1

1.2

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

246

1.26

0.58

1.0

1.1

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

123

1.38

0.57

2.7

8.0

72.40

70.10

—

102

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

1.48

0.57

1.0

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.67

0.56

1.0

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

224

2420

0.92

0.56

1.5

1.6

999.97

1009.80

mu/l

0.06

192

2002

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

139

1257

1.11

0.56

2.1

2.4

101.24

86.16

ug/min

0.22

743

(4212803) Bone marrow aspirate examination

1.46

0.56

1.0

1.1

—

(3019174) dRVVT (LA screen)

1.46

0.56

1.8

1.1

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

0.56

2.6

7.1

12.06

10.60

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

341

0.79

0.55

1.1

—

(3004775) Volume in Urine collected for unspecified duration

407

0.81

0.55

1.9

2.3

574.29

626.39

0.39

270

(40761539) Cells [Type] in Urine sediment by Light microscopy

133

1.35

0.55

1.1

—

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

1.58

0.54

1.0

0.07

0.27

u/ml

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

312

1.22

0.54

1.3

1.4

5.44

5.77

mmol/l

1.44

299

(3004451) EKG impression Narrative

358

1.20

0.53

1.4

1.3

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.45

0.53

1.1

71.11

87.74

titre

—

(3045142) Bone marrow Pathology biopsy report

694

1.14

0.52

1.2

1.4

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

865

0.88

0.52

1.4

1.5

56.30

60.15

ug/l

0.42

865

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

370

1.19

0.50

1.1

1.2

1.09

1.06

ratio

0.33

299

(3027456) Digoxin [Moles/volume] in Serum or Plasma

136

1239

1.10

0.49

3.5

3.4

0.87

0.82

nmol/l

0.35

109

1009

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

316

1.20

0.49

1.2

1.3

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.56

0.48

1.3

1.2

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

209

1943

1.08

0.48

1.3

287.46

224.50

miu/ml

1.34

920

(3018133) Calcium [Moles/volume] in Urine

119

1.35

0.48

2.0

1.9

2.44

2.89

mmol/l

0.39

101

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

190

1.26

0.47

2.4

3.7

4.77

4.91

kpa

0.28

190

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

138

1263

1.09

0.47

1.6

1.5

—

(40768795) Lymph node Pathology biopsy report

635

1.14

0.47

1.2

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

191

1.26

0.46

2.4

3.7

11.74

10.46

kpa

1.08

191

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

366

1.18

0.44

1.7

1.5

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.45

0.44

1.2

1.1

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

1.37

0.44

1.0

0.00

0.93

u/ml

—

(4035726) Immunohistochemistry procedure

574

5521

1.04

0.44

1.4

—

(40768793) Breast Pathology biopsy report

186

1732

1.08

0.43

1.3

—

(3003434) Protein [Mass/volume] in Pleural fluid

809

0.89

0.43

1.3

1.5

32.77

32.09

g/l

0.18

730

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.41

0.43

1.2

1.1

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

1.61

0.43

6.0

3.6

—

(3044007) Cell count panel - Peritoneal fluid

185

0.76

0.43

3.1

2.0

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.41

0.0

1.0

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

141

1.28

0.40

1.7

1.4

25.01

25.43

g/l

0.03

108

(3020618) Glucose [Moles/volume] in Synovial fluid

0.00

0.40

0.0

1.1

—

5.62

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

883

1.10

0.39

1.2

1.1

115.80

117.75

0.23

801

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

0.39

0.0

1.2

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

129

1191

1.08

0.39

4.9

3.5

22.94

26.91

mg/l

0.83

811

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

447

1.14

0.38

1.9

2.0

1.90

1.53

u/field

0.21

231

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.38

0.38

1.1

—

(3000034) Microalbumin [Mass/volume] in Urine

526

0.87

0.37

2.9

3.1

16.92

56.81

mg/l

1.84

389

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

591

1.12

0.37

1.2

—

(3035880) pH of Pleural fluid

311

0.84

0.36

1.2

1.4

7.31

7.41

0.92

207

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.29

0.36

1.0

—

(3034092) Cytoplasmic Ig cells/cells in Blood

0.65

0.35

10.2

9.2

0.18

—

(3014891) Appearance of Pleural fluid

0.63

0.35

1.0

1.6

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.31

0.35

1.1

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.31

0.35

1.1

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.31

0.35

1.1

1.2

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

181

1.22

0.34

1.8

1.6

8.76

8.89

ug/l

0.05

181

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

181

1.22

0.34

2.4

1.9

56637.55

18875.14

e6/l

0.50

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

667

0.90

0.33

2.2

2.4

22.13

29.16

iu/ml

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

350

1.14

0.32

1.7

1.5

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

313

1.15

0.32

1.3

1.2

—

(3000330) Specific gravity of Urine by Test strip

297

3102

0.96

0.32

3.1

3.5

1.02

ratio

1.16

265

2791

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

137

1.24

0.32

1.5

1.3

1.19

1.18

mmol/l

0.26

137

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

1.27

0.30

1.3

1.7

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

109

1016

1.07

0.29

1.4

1.6

—

(40758292) HTLV I+II Ab panel - Serum

107

0.75

0.29

1.4

1.3

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

213

1.17

0.29

2.8

2.6

0.63

0.61

mmol/l

0.65

213

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

387

0.88

0.28

1.7

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

1.28

0.28

1.2

52.99

39.69

mg/l

0.41

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

575

1.10

0.27

1.2

1.4

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

131

1.22

0.27

1.1

1.3

106.19

108.05

0.09

126

(3024263) Appearance of Synovial fluid

321

0.87

0.26

1.9

1.7

—

(3050129) First trimester maternal screen panel - Serum or Plasma

152

1604

0.95

0.26

1.4

1.5

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

206

1.17

0.26

1.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

141

1.21

0.26

1.2

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.23

0.25

1.0

—

(3006462) Nitrate [Presence] in Urine

283

1.13

0.24

3.2

3.6

—

(3044242) Glucose [Moles/volume] in Arterial blood

331

1.12

0.24

1.4

2.1

7.44

7.98

mmol/l

0.60

331

(40768446) Kidney Pathology biopsy report

218

1.15

0.23

1.6

—

(3017569) Oxygen content in Arterial blood

332

1.12

0.23

1.5

2.4

16.41

16.14

0.23

332

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

921

1.07

0.23

1.2

1.1

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

266

2755

0.96

0.22

4.5

5.0

1.60

0.01

255

2599

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.25

0.22

1.4

1.6

305.60

325.38

umol/24h

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.27

0.22

1.6

1.7

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

410

0.90

0.22

1.3

14.53

11.27

u/l

0.60

377

(40768800) Prostate Pathology biopsy report

894

1.06

0.22

1.2

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.21

0.0

2.0

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.21

0.0

1.0

—

(3001218) Citrate [Mass/time] in 24 hour Urine

0.00

0.21

0.0

1.5

—

408.92

—

(3052592) Norovirus Ag [Presence] in Stool

102

0.78

0.21

1.5

1.3

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

102

0.78

0.21

1.9

1.5

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

205

1973

1.04

0.21

1.8

1.9

—

32.21

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

0.21

0.0

1.2

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

770

0.93

0.20

1.4

1.3

7.26

7.27

mmol/l

0.02

679

(3034614) HLA Ag [Interpretation]

0.00

0.20

0.0

1.1

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

202

1.14

0.20

1.2

1.1

—

(3023199) Leukocytes [#/volume] in Pleural fluid

705

0.94

0.19

1.4

1.5

5208.71

3089.94

e6/l

0.40

487

(3045462) Protein/Creatinine [Ratio] in Urine

1.13

0.18

2.2

3.4

60.45

25.76

mg/mmol

—

(3045788) Cell count panel - Pleural fluid

591

0.93

0.18

1.3

1.5

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

194

1.13

0.18

1.0

1.3

87.67

90.11

—

(3020393) Adenovirus Ag [Presence] in Stool

1.21

0.18

1.3

1.2

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

223

1.12

0.18

2.0

1.8

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

223

1.12

0.18

2.0

1.8

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.17

0.17

1.1

1.5

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.17

0.17

1.1

1.3

5.80

5.92

mmol/l

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

252

1.11

0.17

1.1

1.2

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

224

1.12

0.17

2.1

1.8

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

0.75

0.17

1.0

1.1

0.02

0.03

u/ml

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

382

3735

1.02

0.16

2.9

3.8

36.52

65.09

u/ml

2.61

361

3603

(3020876) Protein [Mass/time] in 24 hour Urine

739

1.06

0.16

2.2

2.3

1.23

1.27

g/24h

0.04

427

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

225

0.89

0.16

1.5

1.8

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.11

0.16

1.0

1.1

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.10

0.15

1.0

1.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.79

0.15

1.2

1.4

—

(3012441) Differential panel - Pleural fluid

605

0.94

0.15

1.3

1.5

—

(3013727) Leukocytes other/Leukocytes in Blood

171

0.88

0.14

1.8

3.7

62.33

52.88

0.90

163

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

0.80

0.14

1.0

1.2

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

189

1.11

0.13

1.3

1.1

—

4.87

—

(3029396) Erythrocyte agglutination [Presence] in Blood

132

1.14

0.13

2.8

3.2

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

107

0.84

0.13

1.2

1.7

—

5291.67

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

161

1.12

0.13

1.7

1.4

10.07

12.72

g/l

0.47

123

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

1017

0.96

0.12

1.8

—

(3018572) Chloride [Moles/volume] in Blood

122

1257

0.97

0.10

6.1

7.1

104.60

105.02

mmol/l

0.49

111

1121

(3039000) Anion gap in Blood by calculation

122

1256

0.97

0.10

6.1

7.1

10.58

11.28

mmol/l

2.00

111

1119

(40768441) Liver Pathology biopsy report

466

1.05

0.10

1.6

1.4

—

(3036782) Glucose [Moles/volume] in Pleural fluid

586

0.96

0.10

1.2

1.4

5.51

6.38

mmol/l

1.15

552

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

135

1.11

0.09

2.9

3.2

95.53

127.62

ng/l

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

174

1.09

0.09

1.1

1.2

6.46

12.65

pmol/l

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

635

0.96

0.09

1.3

1.2

—

(3008536) Aspergillus sp Ab [Presence] in Serum

113

0.88

0.08

1.0

1.9

—

(3034459) Mononuclear cells/Leukocytes in Pleural fluid

1.08

0.08

1.0

1.4

78.89

74.56

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

0.84

0.07

1.0

1.7

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

137

1.10

0.07

1.1

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

143

0.91

0.07

1.1

2.0

3.37

2.02

ug/l

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.02

0.07

1.0

1.1

—

(40762365) Oxygen content in Arterial blood by calculation

1.02

0.07

2.9

2.3

14.73

15.05

ml/dl

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

244

0.94

0.06

2.3

3.4

1.22

1.25

0.05

244

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

276

1.05

0.06

2.0

2.1

166.38

130.20

ug/min

—

(40765089) Chromosome analysis panel - Blood by G-banded

141

0.92

0.05

1.0

—

(4195642) Thrombophilia screening test

881

1.02

0.05

1.2

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

333

0.96

0.05

1.0

1.2

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

130

1.08

0.04

1.3

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

476

1.03

0.04

1.3

1.2

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

625

0.98

0.04

1.3

1.4

52322.97

68768.15

e6/l

0.26

340

(3023487) Leukocytes [#/volume] in Peritoneal fluid

211

0.95

0.04

2.6

2.2

381.91

804.08

e6/l

1.30

146

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

328

1.04

0.04

3.1

2.6

45.28

42.85

0.44

184

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

136

1342

1.01

0.04

2.5

3.5

583.51

696.40

u/ml

0.10

128

1217

(3041918) Cholesterol [Moles/volume] in Pleural fluid

111

1.08

0.04

1.3

2.72

1.72

mmol/l

—

(4211845) Urine protein measurement

309

1.04

0.03

3.2

3.5

—

(3034426) Prothrombin time (PT)

191

1.05

0.03

1.2

28.25

28.47

0.05

191

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

410

0.98

0.02

7.4

7.0

10.84

119.63

ug/l

1.20

254

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

392

1.02

0.01

1.7

1.5

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

203

1.03

0.01

1.3

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

652

6508

1.00

0.01

3.5

4.2

30.47

26.31

ug/l

0.06

529

5255

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

1.06

0.01

1.9

1.7

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

456

0.99

0.00

1.1

—

(3042733) HLA Ab [Presence] in Serum

167

1.02

0.00

4.9

5.2

—

(40765096) Chromosome analysis panel by Banding

177

1.02

0.00

1.1

—

(3016750) Collection duration of Urine

297

1.01

0.00

1.8

2.3

463.82

495.28

min

0.67

221

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

196

1.02

0.00

1.1

89.57

90.25

—

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

155

1.03

0.00

1.4

39.00

35.76

—

103

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

102

0.98

0.00

1.0

1.4

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

149

1.01

0.00

1.3

101.35

407.50

ug/l

—

(3009992) Blasts/cells in Bone marrow

0.00

0.0

1.8

—

5.50

—

(3027305) Fractional oxyhemoglobin in Arterial cord blood

0.00

0.0

1.2

—

36.93

—

(3008343) Lysozyme [Mass/volume] in Urine

0.00

0.0

1.0

—

0.47

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

0.00

—

(3001729) Color of Synovial fluid

0.93

-0.00

1.2

1.6

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

-0.00

0.0

1.4

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

0.85

-0.00

1.0

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.0

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.2

—

(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.2

—

(3027859) Formaldehyde IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3043410) Blood group antigens tested for on Red Blood Cells

150

1.00

-0.00

1.1

1.7

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

0.00

-0.00

0.0

1.1

—

170.87

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

-0.00

0.0

7.0

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

1.00

-0.00

13.6

12.3

9.24

5.43

mmol/l

—

(4133840) Spirometry

130

1.00

-0.00

1.3

1.2

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint G6_RLS and mortality.

Females

Parameter	HR [95% CI]	p-value
G6_RLS	1.061 [0.92, 1.23]	0.425
Birth year	0.993 [0.98, 1.0]	0.087

During the follow-up period (1.1.1998 — 31.12.2019), 1342 out of 10279 females with G6_RLS died.

Males

Parameter	HR [95% CI]	p-value
G6_RLS	1.246 [1.07, 1.45]	0.004
Birth year	0.988 [0.98, 1.0]	0.009

During the follow-up period (1.1.1998 — 31.12.2019), 1193 out of 6145 males with G6_RLS died.

Mortality risk

Mortality risk for people of age

years, who have G6_RLS.

N-year risk	Females	Males
1	0.061%	0.23%
5	0.57%	1.436%
10	1.463%	3.607%
15	2.728%	6.773%
20	4.931%	11.498%

Relationships between endpoints

↥

Index endpoint: G6_RLS – Restless leg syndrome

GWS hits: 16

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Restless leg syndrome

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints